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ABSTRACT
THE EFFECTS OF SODIUM BICARBONATE SUPPLEMENTATION ON
LOWER-BODY HYPERTROPHY-TYPE RESISTANCE EXERCISE
by Benjamin McLean Carr
May 2011
Introduction: A number of studies have demonstrated the ergogenic effects of
induced-alkalosis on high-intensity intermittent exercise performance. Purpose: The aim
of the present study was to examine the effects of sodium bicarbonate (NaHCO3)
administration on a high-volume hypertrophy-type resistance exercise regimen for the
lower body. Methods: In a double-blind counterbalanced manner, 12 resistance-trained
male participants (mean ± SD; age = 20.3 ± 2 yr, mass = 88.3 ± 13.2 kg, height = 1.80 ±
0.07 m), with a minimum of two years of training experience, ingested either 0.3 g·kg-1 of
NaHCO3 or calcium carbonate (CaCO3) Placebo, divided into four even doses
administered every 10 min, with the last dose being consumed approximately 60 min
before the initiation of a hypertrophy-type resistance exercise (HRE) regimen for the
lower body. The HRE protocol employed multiple exercises [back squat (SQ), inclined
leg press (LP), and knee extension (KE)] utilizing four sets each, with 10- to12-RM (~6575% 1-RM) loads and short rest periods ranging from 60-90 s between sets. Exercise
performance was determined by total repetitions generated during each exercise,
repetitions accumulated throughout the exercise protocol, and a performance test (PT)
involving a fifth set of KE to failure utilizing loads of approximately 50% 1 RM.
Arterialized capillary blood samples were extracted via fingertip puncture at four time
points and subsequently analyzed for pH, bicarbonate concentration ([HCO3-]), base
ii

excess (BE), and lactate concentration ([Lac-]) by a portable clinical blood-gas analyzer.
Results: Prior to exercise and relative to Placebo ingestion, NaHCO3 significantly
elevated pH (mean ± SD; NaHCO3: 7.49 ± 0.02, Placebo: 7.42 ± 0.02, P < 0.05), [HCO3-]
(NaHCO3: 31.50 ± 2.59, Placebo: 25.38 ± 1.78 mEq·l-1, P < 0.05), and BE (NaHCO3:
7.92 ± 2.57, Placebo: 1.08 ± 2.11 mEq·l-1, P < 0.05). NaHCO3 administration resulted in
significantly more total repetitions (SQ + LP + KE) than Placebo (NaHCO3: 139.8 ±
13.2, Placebo: 134.4 ± 13.5), as well as significantly greater arterialized-capillary blood
[Lac-] immediately after the exercise protocol (NaHCO3: 17.92 ± 2.08, Placebo: 15.55 ±
2.50 mM, P < 0.05). There were no significant differences between group PT repetitions
(NaHCO3: 23.8 ± 4.0, Placebo: 22.3 ± 3.7), although overall total repetitions (SQ + LP +
NE + PT) remained significantly higher for the NaHCO3 condition (NaHCO3: 163.7 ±
15.1 Placebo: 156.7 ± 14.5). Conclusions: Administration of 0.3 g·kg-1 NaHCO3 resulted
in significantly more total repetitions accumulated throughout the exercise regimen.
These findings demonstrate ergogenic efficacy for NaHCO3 administration during HRE
and warrant further practical investigation into the effects of induced-alkalosis on the
adaptations occurring during chronic HRE training.
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CHAPTER I
INTRODUCTION
Hypertrophy-Type Resistance Exercise
Training with resistance exercise (e.g., weightlifting) has substantially increased
in popularity over the past several decades. Individuals engage in resistance training for a
variety of reasons, among those being to improve athletic performance, enhance general
fitness, and to rehabilitate after injury (Fry, 2004). One of the most noticeable adaptations
to chronic resistance training is an increase in skeletal muscle size, or hypertrophy (Bird,
Tarpenning, & Marino, 2005). Muscle hypertrophy, which can be further defined as an
increase in muscle cross-sectional area (Brooks, Fahey, White, & Baldwin, 2000), is of
interest not only to athletes seeking to optimize performance, but also to individuals
seeking improvements in body composition or increased capacity to perform the tasks of
daily living (Bird et al., 2005). Skeletal muscle tissue is characterized by plasticity, with
muscle readily adapting to imposed demands (Coffey & Hawley, 2007). Muscle
hypertrophy is an adaptation that takes place when muscle must contract against
increasingly heavier loads over time (Haddad & Adams, 2002). Training with
progressively heavier loads, if done in the proper fashion, can lead to hypertrophy in both
younger men (McCall, Byrnes, Dickinson, Pattany, & Fleck, 1996) and women (Kraemer
et al., 2004), as well as older adults (Campbell, Crim, Young, & Evans, 1994). Exercise
designed to enhance muscle growth will be referred to as hypertrophy-type resistance
exercise (HRE) throughout this document.
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HRE Regimen Design
The specific muscular adaptations obtained through resistance exercise are
dependent upon training program design. Resistance training programs that target muscle
hypertrophy are distinctive from those programs that target muscular strength or
endurance (Baechle, Earle, & Wathen, 2008). The American College of Sports Medicine
(ACSM) has identified several acute variables associated with program design (ACSM,
2009). Of primary interest here are the variables of exercise load, exercise volume,
exercise selection, exercise order, and rest periods.
Exercise load. A single bout of resistance exercise increases anabolic hormone
concentrations, thereby potentiating the effects of hormone-tissue interaction (Crewther,
Keogh, Cronin, & Cook, 2006). One of the most notable effects of this interaction is the
muscle hypertrophy that accompanies resistance training. The proper design of a
resistance training regimen is therefore essential in modulating the hormonal response
and subsequent hypertrophy to exercise (Crewther et al., 2006). Muscle hypertrophy only
occurs when there is a net protein accretion in which protein synthesis exceeds protein
catabolism (Tipton & Wolfe, 2001). In order for muscle protein synthesis to occur,
muscle must receive an adequate stimulus (Tipton & Wolfe, 2001). Without an adequate
stimulus, the mechanisms responsible for muscle growth will function at a less than
optimal capacity for maximizing hypertrophy (Spiering et al., 2008). Stimulus, or
intensity, can be expressed in terms of exercise load. The load, which is possibly the most
important design variable, is defined as the amount of weight lifted during each exercise
set (Baechle et al., 2008). The appropriate load, or prescribed training intensity, is
dependent upon the desired adaptation or training goal. Load is typically prescribed as a
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percentage of the one-repetition maximum (1-RM)—the amount of weight that can be
lifted only one time for a given exercise (e.g., 75% 1-RM). Load can also be prescribed
as a multiple RM (Spiering et al., 2008). Multiple RM refers to the number of repetitions
that can be completed until a point of momentary muscular failure or exhaustion (e.g., 5RM). Repetition maximum values fall along a continuum and are related to specific
training effects such as muscular endurance, strength, or power (Spiering et al., 2008).
Skeletal muscle growth is directly related to motor-unit activation. Based on the
size principle, the smaller motor units typically associated with type I muscle fibers are
recruited first. As greater muscular force is needed to either maintain or increase work
output, the larger type II motor units are increasingly recruited (Spiering et al., 2008).
Since type II muscle fibers possess the greatest propensity for growth (McCall et al.,
1996), relatively heavy loads should be lifted to a point of momentary muscular failure to
maximize hypertrophy (Spiering et al., 2008). For HRE, the load has traditionally been
set at 8- to 12-RM, while strength and muscular endurance programs set the loads at 1- to
6-RM and 15- to 25-RM, respectively (Fleck & Kraemer, 1988; Spiering et al., 2008).
Failing to use an intensity that results in momentary muscular failure at approximately 10
repetitions may not be stressful enough to create the metabolic and hormonal
environment to induce hypertrophy (Linnamo, Pakarinen, Komi, Kraemer, & Hakkinen,
2005). Setting the load at 8-12-RM increases total work output (Moss, Refsnes,
Abildgaard, Nicolaysen, & Jenson, 1997) and maximizes the anabolic hormonal response
(Gotshalk et al., 1997; Linnamo et al., 2005), ultimately creating the proper internal
environment to facilitate hypertrophy (Kraemer et al., 1990).
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Exercise volume. Exercise volume is the total amount of work performed during
an exercise set or regimen and is typically expressed as total repetitions, calculated as
number of sets multiplied by the number of repetitions performed in each set (Baechle et
al., 2008). As with exercise load, total exercise volume affects the magnitude of the
anabolic hormone response. Even though single-set exercises have been shown to induce
hypertrophy in untrained individuals, multiple-set, higher volume regimens appear to be
superior for stimulating greater hypertrophy, especially as resistance training experience
advances (Ronnestad et al., 2007). A HRE regimen, with a relatively high number of sets
and total repetitions, elicits the greatest growth hormone response (Gotshalk et al., 1997).
Growth hormone, which is actually comprised of a family of anabolic polypeptide
hormones, is a potent anabolic agent and is highly sensitive to resistance exercise loads
and overall volume. Hypertrophy schemes have elicited a growth hormone concentration
that is, on average, eight times higher than that seen with power or strength schemes
(Crewther et al., 2006). Lactate accumulation is thought to be one of the stimulators of
growth hormone secretion (Gordon, Kraemer, Vos, Lynch, & Knuttger, 1994). It has
been shown that, with regard to resistance exercise, the largest increase in lactate
concentration is seen with exercise regimens that have the greatest volume (Linnamo et
al., 2005). There is also a possible link between lactate accumulation and elevated
testosterone concentration, which further suggests that HRE regimens are effective in
eliciting the hormonal environment necessary for muscle growth (Lu et al., 1997).
Rest periods. Another important determinant of the hypertrophic response to
resistance exercise is the length of the rest periods. Rest period, which can be defined as
the time between exercise sets or exercises, is related to exercise intensity and is
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dependent upon training goals (Bird, et al., 2005). Rest period length has a significant
effect on resistance exercise-induced adaptations (Spiering et al., 2008). For hypertrophy
development, shorter rest periods lead to larger increases in total work output and
circulating anabolic hormones (Kraemer, Noble, Clark, & Culver, 1987). For this reason,
it is often recommended that HRE regimens have rest periods ranging from one to two
minutes (Bird et al., 2005). Some research suggests that even shorter rest periods of 3060 seconds (s) may be optimal (de Salles et al., 2009). However, while shorter rest
periods may be advantageous for novice or intermediate lifters, more advanced lifters
may need approximately one to three minutes, depending on exercise type and intensity,
with multi-joint, large musculature exercises typically requiring the greatest amount of
rest between sets (ACSM, 2009). In general, though, the shorter rest periods utilized with
hypertrophic schemes (e.g., one minute between sets) are superior to the longer rest
periods seen with strength and power schemes (e.g., three to five minutes between sets)
in terms of facilitating muscle growth (de Salles et al., 2009).
Exercise selection and order. Two final important acute design variables are
exercise selection and exercise order. Exercise selection refers to the process of choosing
those exercises that will be included in a resistance training regimen (Baechle et al.,
2008). Exercises may be classified as single-joint or multi-joint, with the latter involving
two or more joints and requiring greater muscular effort (Bird et al., 2005). Exercises that
utilize large muscle groups, such as the back squat, significantly invoke those hormonal
and metabolic processes necessary for muscle growth (Spiering et al., 2008). Even
though multi-joint exercises require greater muscle mass, both multi- and single-joint
exercises can promote hypertrophy and are both typically included in resistance training
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regimens (Bird et al., 2005). Exercise order, or the sequence of exercises performed
within an exercise session, should typically progress from exercises involving the more
energetically demanding larger musculature to less demanding exercise involving smaller
musculature (Hickson, Buono, Wilmore, & Constable, 1984). Multi-joint exercise
performance declines when these exercises are performed later in an exercise regimen;
therefore, exercises involving multiple joints and large musculature should be performed
at the beginning of the resistance exercise session (Spreuwenberg et al., 2006).
Performing large musculature, multi-joint exercises at the beginning of a training session
also maximizes the total work output over the entire exercise session (Sforzo & Touey,
1996) and elevates anabolic hormone concentrations, potentiating hormone-tissue
interaction for exercises occurring later in the session (Bird et al., 2005).
Summary. Hypertrophy-type resistance exercise regimens are characterized by
moderate loads, short rest periods, and high total volume. Exercise loads should be set at
approximately 8-12-RM, with rest periods of approximately one minute between sets.
Performing multiple sets of an exercise is superior to a single set, with greater total
exercise volumes eliciting greater concentrations of the anabolic hormones. Both singleand multi-joint exercises may be performed, with the multi-joint, large musculature
exercises being performed at the beginning of the exercise session.
Fatigue During HRE
Typical HRE regimens, as detailed above, can be classified as high-intensity,
intermittent exercise, characterized by heavy periods of activity interspersed with brief
rest periods. The fatigue associated with this type of exercise (i.e., brief intervals of
maximal effort) is likely to be multi-faceted (Lambert & Flynn, 2002). Fatigue, which
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can be defined as a reduction in muscular force producing capabilities, is associated with
both central and peripheral factors (Boerio, Jubeau, Zory, & Maffiuletti, 2005). However,
the primary site of fatigue during intense exercise appears to be peripheral, occurring
within the muscle cell, or fiber (Fitts, 1994).
Sources of Fatigue
Hypertrophy-type resistance exercise is intense and prolonged. For example,
bodybuilders seeking to maximize hypertrophy may perform anywhere from 15 to 20 sets
of exercises for one muscle group, with limited recovery between sets (Lambert & Flynn,
2002). As previously stated, the fatigue during this type of resistance exercise is multifaceted, and the specific cause of fatigue is often difficult to elucidate. During intense
exercise, multiple energy substrates are depleted with the concurrent accumulation of
metabolites, making it difficult to determine if energy depletion or metabolic
intermediate/end-product accumulation is the primary cause of fatigue. For example,
during intense exercise, phosphocreatine (PCr) and glycogen are depleted (Lambert &
Flynn, 2002), while hydrogen ions and adenosine diphosphate (ADP) accumulate (Miller,
Boska, Moussavi, Carson, & Weiner, 1988). Resistance exercise confounds the problem
since the source of fatigue during the first set of 10 repetitions to muscular failure is
likely different from the primary source of fatigue during the later exercise sets (Lambert
& Flynn, 2002).
Substrate depletion. The primary contributors to fatigue during HRE are thought
to be PCr and glycogen depletion and metabolic acidosis (Lambert & Flynn, 2002),
although more recent evidence suggests that the accumulation of inorganic phosphate (Pi)
that accompanies rapid adenosine triphosphate (ATP) hydrolysis may play a more
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significant role than previously thought (Mougios, 2006). PCr serves as an important
immediate source of ATP replenishment, but due to limited supplies, PCr stores are
significantly reduced in a matter of seconds during high-intensity exercise. This substrate
depletion is highly correlated with fatigue (Sahlin, Tonkonogi, & Soderlund, 1998),
especially after one, 10-RM set of resistance exercise (Lambert & Flynn, 2002).
MacDougall et al. (1999) established that total muscular force-producing capacity was
reduced only 20% following one set approaching momentary muscular failure
(approximately 12-RM). This suggests that one maximal set of exercise fatigues the
muscle, but does not exhaust it. According to an analysis by Lambert & Flynn (2002) of
the MacDougall et al. study (1999), the energy to complete one, 12-RM set was derived
as follows: 1.6% from stored ATP, 16.3% from PCr hydrolysis, and 82.1% from
glycolysis (or glycogenolysis). The large contribution from glycolysis can be explained
by the fact that PCr hydrolysis can only sustain maximal activity for approximately 10 s
(Cramer, 2008), and resistance exercise sets of approximately 12 repetitions may last 3540 s (Lambert & Flynn, 2002). Larger contributions from anaerobic glycolysis are
necessary to sustain near maximal exercise for this length of time (Matson & Tran, 1993).
Lambert and Flynn (2002) suggest that glycogen depletion could be a source of
fatigue during repeated bouts of very intense exercise due to preferential utilization of
type II muscle fibers during HRE. Glycogen concentration is substantially higher in type
II fibers, and the rate of glycogenolysis in type II fibers has been reported as being 62%
faster than the rate in type I fibers during 30 s of maximal treadmill sprinting (Greenhaff
et al., 1994). When analyzing single muscle fibers following biopsy, Nicholas et al.
(1999) found that glycogen was more significantly depleted in type II fibers, in
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comparison to type I fibers, following a high-intensity intermittent exercise protocol.
Research has shown that one elbow flexor exercise set at approximately 12-RM (80% 1RM) resulted in a 12% decrease in glycogen concentration of the biceps brachii, while
three sets at 80% 1-RM resulted in a 24% decrease in glycogen concentration
(MacDougall et al., 1999). Similar research has shown that one set of leg extensions at
70% 1-RM (~12-13 repetitions) resulted in a 26.1% decrease in glycogen content of the
vastus lateralis, with six sets resulting in a 38% decrease in glycogen (Robergs et al.,
1991). Although the study by Greenhaff et al. (1994) indicated heavy reliance on type II
fiber glycogenolysis during maximal sprinting, significant glycogen stores still remained
after the 30 s of activity. This 30-s bout of maximal activity is akin to one set of
resistance exercise taken to momentary muscular failure. Taken together, these studies
suggest that, while glycogen depletion is not a source of fatigue during one set of
maximal activity, glycogen depletion could become a source of fatigue during repeated
bouts of very intense exercise (Lambert & Flynn, 2002).
Acidosis. Having established that glycolysis is a major source of ATP production
during HRE, the focus now turns to acidosis-related fatigue. The glycolysis primarily
involved during high-intensity resistance training is termed anaerobic, or fast, glycolysis
and results in lactate production (Cramer, 2008). As the body relies heavily on anaerobic
glycolysis for ATP, there are large increases in intracellular hydrogen ion (H+) and lactate
concentrations (acidosis) (Medbo & Tabata, 1993). This glycolysis-coupled H+
production has historically been thought to be the greatest contributor to metabolic
acidosis (Juel, 1998). However, this line of reasoning has drawn criticism, with some
researchers suggesting that the extensive ATP hydrolysis occurring during muscle
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contraction is the major source of H+ (Robergs, Ghiasvand, & Parker, 2004). Whatever
the case may be, high-intensity exercise is strongly associated with increasingly acidic
intra- and extracellular pH, and this acidosis is often implicated as a major source of
fatigue (Materko, Santos, & Novaes, 2008; Sahlin et al., 1998).
Acidosis mechanisms of fatigue. There are several mechanisms by which acidosis,
or H+ accumulation, is suspected to contribute to fatigue. Acidosis reduces actomyosin
ATPase activity, which in turn likely reduces cross-bridge turnover rates (Allen,
Westerblad, & Lannergren, 1995). This interference in actin-myosin coupling has been
shown to reduce muscle force generating capacity (Spriet, Matsos, Peters, Heigenhauser,
& Jones, 1985). There may also be a reduced affinity of troponin for calcium (Ca2+) due
to competitive H+ interference, which would reduce force generating capacity as well
(Chin & Allen, 1998). Excessive H+ is also associated with disturbances in normal Ca2+
and potassium (K+) activity within the muscle fiber. Acidosis appears to interfere with
both Ca2+ release and sequestering by the sarcoplasmic reticulum (Fitts, 1994), and this
interference in Ca2+ equilibrium is thought to contribute to the development of fatigue
(Mougios, 2006). In terms of K+ equilibrium, acidosis is associated with an efflux of K+
from the cell, which could reduce sarcolemma excitability and, consequently, muscle
fiber force production (Broch-Lips, Overgaard, Praetorius, & Nielsen, 2007). Excessive
H+ may also interfere with ATP-generating processes. Acidosis inhibits glycolysis, likely
through the inhibition of phosphofructokinase activity (Sutton, Jones, & Toews, 1981).
Acidosis also interferes with creatine kinase equilibrium, which could reduce the rate of
ATP resynthesis (Sahlin et al., 1998). These effects of H+ accumulation are likely key
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contributors to the muscular fatigue, or reduction in force producing capabilities,
experienced during HRE.
Attenuating Acidosis
As acidosis can be detrimental to cellular functioning, the body needs
mechanisms to remove excessive H+. Resting intracellular pH is slightly alkaline, with an
approximate value of 7.2 (Juel, 1998, 2008). Resting extracellular pH is slightly more
alkaline at approximately 7.4 (Juel, 2008). Although the human body is fairly resistant to
large fluctuations in pH, intense exercise may result in a decrease in intra- and
extracellular pH to approximately 6.5 and 6.9, respectively (Coombes & McNaughton,
1993). Since pH is calculated as the negative logarithm of the H+ concentration, a
decrease in 1.0 pH unit represents a ten-fold increase in hydrogen ions (McNaughton,
2002). To attenuate the accumulation of H+, the body employs several H+ transport and
buffer systems. While buffers “tie up” H+, transporters move H+ between intra- and
extracellular compartments. The two most quantitatively important transporters for H+
removal are the Na+/H+ exchangers and lactate/H+ co-transporters, with the latter serving
a more important role during high-intensity exercise (Juel, 2008).
Buffers. The presence of a buffer in a system allows for more acid (H+) to be
added to that system before affecting a change in pH (Juel, 2008). The buffering of acids
to maintain physiologic pH can be referred to as acid-base balance. There are three
primary buffer systems utilized by the body to maintain acid-base balance: respiratory,
renal and chemical (Guyton & Hall, 1996). The respiratory mechanisms comprise the
second line of defense against acidosis, acting in a couple of minutes to attenuate acidosis
by removing carbon dioxide (CO2), while the renal system is the last line, slowly
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correcting acidosis through the secretion of acidic urine (Guyton & Hall, 1996). The
chemical buffers are the first line of defense against acidosis, reacting within a fraction of
a second, and are the focus of the present study. The chemical buffers are comprised of
proteins (e.g., hemoglobin and albumin), small peptides (e.g. carnosine), dibasic Pi, and
bicarbonate (Juel, 2008; Sahlin, Alvestrand, Brandt, & Hultman, 1978). While
hemoglobin and plasma proteins are quantitatively important extracellular buffers
(Medbo, Noddeland, & Hanem, 2009), the bicarbonate system is regarded as the most
important extracellular buffering system for maintaining acid-base balance (Guyton &
Hall, 1996). Indeed, bicarbonate has been shown to buffer approximately 62% of the
hydrogen ions released to blood during exhaustive cycling (Medbo et al., 2009). The
bicarbonate system is depicted below (McNaughton, Siegler, & Midgley, 2008):
H+ + HCO3- ↔ H2CO3 ↔ CO2 + H2O
Bicarbonate. In the above reversible reaction, H+ combines with the bicarbonate
ion (HCO3-) to produce carbonic acid (H2CO3), which readily dissociates into CO2 and
water (H2O) (Guyton & Hall, 1996). Simplistically, the CO2 generated travels through the
blood and is eliminated at the level of the lungs, effectively eliminating H+ from the
system (McNaughton et al., 2008). Whether or not intracellular acidosis occurs as a result
of H+ accumulation is dependent upon the rates of H+ production and removal (Roussel et
al., 2003). The intra- and extracellular buffer systems, as well as the H+ transport
systems, work to reduce the build-up of the free H+ that occurs during high-intensity
exercise (Bishop, Edge, Davis, & Goodman, 2004). Efflux of H+ from the cell to the
extracellular fluids depends on the H+ concentration both inside and outside of the cell.
While acidosis of the extracellular fluids inhibits the efflux of H+ from the cell
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(Mainwood & Worsley-Brown, 1975), an increase in extracellular HCO3- creates a pH
gradient that promotes H+ efflux, subsequently attenuating reductions in intracellular pH
(McNaughton et al., 2008). Given that excessive H+ appears to have deleterious effects
on muscle cell functioning, researchers have taken interest in methods to elevate the pH
gradient between the intra- and extracellular environments. Since HCO3- does not readily
permeate the sarcolemma (Mainwood & Cechetto, 1980), much of the research has
centered on elevating extracellular HCO3- concentrations (McNaughton et al., 2008).
Historically, most attempts to elevate extracellular HCO3- concentrations have utilized
sodium bicarbonate (NaHCO3) supplementation (Webster, 2002).
Summary. The fatigue experienced during high-intensity, intermittent exercise,
such as HRE, likely has multiple sources. Anaerobic glycolysis provides the majority of
the ATP for muscle contraction during a set of HRE. In conjunction with extensive ATP
hydrolysis, extensive anaerobic glycolysis generates excessive H+. An accumulation of
H+, and the consequent drop in pH, inhibits muscle force production. There are various
proposed mechanisms of this fatigue, such as interference with the excitation-contraction
coupling processes and inhibition of energy producing reactions. The human body is
equipped with mechanisms to attenuate excessive H+, among those being H+ transporters
and intra- and extracellular buffers. The bicarbonate system is the most important
chemical extracellular buffer, correcting for decreases in pH in a fraction of a second.
Elevation of extracellular HCO3- creates a pH gradient and facilitates efflux of H+ from
the muscle fiber. This attenuation of acidosis can prevent or minimize the deleterious
effects of H+ accumulation and potentially enhance exercise. The most common means of
elevating extracellular HCO3- has been NaHCO3 supplementation.
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CHAPTER II
REVIEW OF LITERATURE
Ergogenic Effects of Sodium Bicarbonate
Interest in attenuating exercise-induced acidosis as a means of exercise
performance enhancement in humans spans nearly ten decades, with some of the initial
alkalosis-related research being conducted in the early 1930s (Dennig, Talbot, Edwards,
& Dill, 1931; Dill, Edwards, & Talbot, 1932). The modern era of research in NaHCO3
supplementation began in the late 1970s and continues today. A number of reviews are
available to help sift through the extensive NaHCO3 supplementation data (Linderman &
Gosselink, 1994; Matson & Tran, 1993; McNaughton, 2002; McNaughton et al., 2008;
Requena, Zabala, Padial, & Feriche, 2005; Webster, 2002). This review of literature will
primarily focus on a subset of the NaHCO3 literature, namely those studies examining the
effect of NaHCO3 supplementation on high-intensity, intermittent exercise (HIE).
However, before delving into those specific HIE studies, some of the extensive
information contained in previous studies and reviews will be synthesized where
appropriate.
NaHCO3 Supplementation
NaHCO3 (i.e., baking soda) is an alkalizing salt that dissociates into sodium (Na+)
and HCO3- when dissolved in solution (Wear, McPherson, & Kolling, 2010). NaHCO3,
whether administered intravenously or orally, has been shown to elevate the HCO3reserve in the blood (Maughan et al., 1986; Price et al., 2003; Siegler & Hirscher, 2010;
Webster et al., 1993). This increase in extracellular HCO3- concentration is the primary
rationale behind NaHCO3 administration for attenuation of acidosis, since a more alkaline
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extracellular environment creates a pH gradient and facilitates H+ efflux (Aschenbach et
al., 2000; Stephens, McKenna, Canny, Snow, & McConell, 2002). This increase in H+
efflux is likely due to the activity of the lactate/H+ co-transporter, which is upregulated in
response to an increasing pH gradient (Roth, 1991). It has also been postulated that the
Na+ resulting from the NaHCO3 dissolution has possible ergogenic, or performance
enhancing, effects as well (Mitchell et al., 1990). The potential benefits are attributed to
an increase in plasma volume and tissue perfusion due to the Na+ load (Mitchell et al.,
1990), an increase in H+ efflux due to upregulation of the Na+/ H+ exchanger (Bishop et
al., 2004), or an elevation of extracellular HCO3- due to disturbances in strong ion
equilibrium (Heigenhauser & Jones, 1991). Whether Na+ confers any ergogenic effects is
equivocal (Aschenbach et al., 2000; Kozak-Collins, Burke, & Schoene, 1994), and Na+
currently remains a component of a commonly used placebo sodium chloride (NaCl) in
NaHCO3 research (Price & Simmons, 2010; Siegler & Hirscher, 2010).
Alkalizing agents. NaHCO3 has been used to induce alkalosis in numerous studies
utilizing a variety of exercise modes. For example, the effects of NaHCO3 administration
have been examined with treadmill sprinting (van Montfoort, van Dieren, Hopkins, &
Shearman, 2004), competitive running (Goldfinch, McNaughton, & Davies, 1988;
Wilkes, Glendhill, & Smyth, 1983), cycle ergometry (Stephens et al., 2002), arm
ergometry (Aschenbach et al., 2000), swimming (Zajac, Cholewa, Poprzecki,
Waskiewicz, & Langfort, 2009), rowing (Brien & McKenzie, 1989), rhythmic handgripping (Nielsen, Hein, Svendsen, Secher, & Quistorff, 2002), interval training (Edge,
Bishop, & Goodman, 2006), resistance exercise (Webster, Webster, Crawford, &
Gladden, 1993; Portington et al., 1998), judo (Artioli et al., 2007), boxing (Siegler &
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Hirscher, 2010), water polo (Tan et al., 2010), and other sport-specific performance tests
(Bishop & Claudius, 2005; Wu, Shih, Yang, Huang, & Chang, 2010). Although NaHCO3
is the most frequently utilized alkalosis-inducing ergogenic aid (Requena et al., 2005),
NaHCO3 is not the only alkalizing agent that has been used in exercise-related research.
Sodium salts of citrate (Potteiger, Nickei, Webster, Haub, & Palmer, 1996; van Someren
et al., 1998), acetate (Smith, Jeukendrup, & Ball, 2007), and lactate (van Montfoort et al.,
2004) have all been used to induce alkalosis. Next to NaHCO3, sodium citrate (Nacitrate) has been the most prevalently used aid to attenuate acidosis (McNaughton &
Cedaro, 1992; Oopik, Saaremets, Medijainen, Karlson, Janson, & Timpmann, 2003;
Parry-Billings & MacLaren, 1986). Although studies have shown Na-citrate to elevate
pH and extracellular HCO3- (Parry-Billings & MacLaren, 1986; van Someren et al.,
1998), evidence of enhanced buffering and performance is lacking (Robergs, 2002). The
exact mechanisms of Na-citrate-induced alkalosis have yet to be elucidated, with the
hypothesis of electrical equilibrium disturbances gaining recent support (Requena et al.,
2005; Robergs, 2002). However, some research suggests that the chemical properties of
citrate inherently make it a poor blood buffer (Robergs, 2002). Along these lines, van
Someren (1998) found that Na-citrate is not an effective ergogenic aid for HIE, a form of
exercise that results in the excessive accumulation of H+ (Matson & Tran, 1993). On the
other hand, numerous studies utilizing NaHCO3 administration have shown strong
ergogenic potential for protocols involving HIE (Requena et al., 2005); therefore,
NaHCO3 will remain the focus here.
NaHCO3 reviews. Resistance exercise, especially HRE, falls under the broader
genre of HIE (Lambert & Flynn, 2002). The effects of NaHCO3 administration have been
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examined on a variety of exercise types, including HIE. While many past NaHCO3
investigations have produced equivocal results (Linderman & Gosselink, 1994), several
recent reviews elucidate the effects of NaHCO3 on different types of exercise
(McNaughton et al., 2008; Requena et al., 2005; Webster, 2002). Webster (2002) divided
NaHCO3 studies into four general types based on duration and intensity of exercise—
power, anaerobic, oxidative, and interval. Along these same lines, Requena et al. (2005)
and McNaughton et al. (2008) grouped studies based on exercise characteristics. Requena
et al. (2005) grouped studies that utilized high-intensity, short-term exercise (< 120 s),
those that contained repeated-bout protocols, and those involving high-intensity, long
term exercise (> 120 s). Similar to this method, McNaughton et al. (2008) divided studies
into the following three groups: high-intensity exercise, prolonged continuous exercise,
and prolonged intermittent exercise. According to Webster (2002), power exercises last
from three to 30 s and rely heavily on the phosphagen system. The author indicates that
there is little rationale or supporting literature for NaHCO3 use during this type of
exercise (Webster, 2002). Requena et al. (2005) are in agreement, suggesting that
exercise of insufficient duration is not enhanced due to minimal acid-base disturbances.
The most consistently examined exercise type relative to NaHCO3 supplementation has
been anaerobic exercise (McNaughton et al., 2008; Webster, 2002). Webster (2002)
defines anaerobic exercise as maximal exercise lasting one to seven minutes. Well
designed and controlled studies examining the effects of NaHCO3 supplementation for
this type of exercise have been some of the most consistent in demonstrating an
ergogenic effect (Matson & Tran, 1993; Webster, 2002). Less consistent are the effects
seen with prolonged endurance, or aerobic, performance (McNaughton et al., 2008;
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Webster, 2002). Aerobic exercise is defined as submaximal or maximal exercise lasting
at least 10 minutes (min) in duration (Webster, 2002). Although most early investigations
into the effects of induced-alkalosis on aerobic performance indicated no effects
(Webster, 2002), recent studies have indicated ergogenic potential, making the results
difficult to interpret (McNaughton et al., 2008).
NaHCO3 and HIE. The last exercise type identified by Webster (2002) is interval
exercise, characterized by repeated bouts of activity with relatively short rest periods
between bouts. This type of exercise, which may also be referred to as repeated-bouts
exercise (Requena et al., 2005) or prolonged intermittent exercise (McNaughton et al.,
2008), includes resistance exercise. As noted by Lambert and Flynn (2002), a source of
fatigue during HRE is the acidosis that occurs due to extensive anaerobic glycolysis.
While there is evidence to suggest that NaHCO3 supplementation may be beneficial to
intermittent exercise such as HRE (Webster, 2002), there have been relatively few studies
conducted examining the effects of an alkalizing agent on resistance exercise. Only six
published studies have been identified that examine the effects of induced-alkalosis on
some type of resistance exercise (Coombes & McNaughton, 1993; Materko et al., 2008;
Maughan, Leiper, & Litchfield, 1986; Portington et al., 1998; Verbitsky, Mizrahi, Levin,
& Isakov, 1997; Webster et al., 1993). Since resistance exercise is a form of HIE, results
from studies examining other HIE modes can be extrapolated to HRE (Lambert & Flynn,
2002). As such, this review focuses on the effects of NaHCO3 supplementation on HIE.
Twenty-nine studies, spanning four decades, were selected for more extensive review
based on the following criteria: NaHCO3 must have been used as the alkalizing agent;
NaHCO3 must have been administered orally; and the research protocol must have
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involved HIE (i.e., intervals, with minimal rest periods) or resistance exercise. Table 1
summarizes the selected studies, with special emphasis on supplementation and exercise
protocols and performance results. These emphases will be further detailed below.
Supplementation Protocols
Dosage. Before discussing dosing protocols of the selected HIE studies, a
preliminary examination of other research is warranted. A dosage of 0.3 grams per
kilogram of body mass (g·kg-1) has been the most frequently administered dose of
NaHCO3 (Webster, 2002), with this amount being based, at least in part, on previous
research. Horswill et al. (1988) examined the dose-response relationship of NaHCO3
supplementation on cycle sprints by administering doses of 0.1, 0.15, and 0.2 g·kg-1.
Although performance was not enhanced, the authors found that all doses significantly
elevated plasma HCO3-, with 0.2 g·kg-1 having the greatest effect. While all three doses
elevated pH over placebo, there were no differences between groups. It is interesting to
note that most significant elevations in pH are in the range of 0.05 to 0.1 units above
resting values, and these elevations are not always strongly correlated with dosage
(Webster, 2002). McNaughton (1992) examined the effects of doses ranging from 0.1 to
0.5 g·kg-1 on 60-s cycle ergometry performance. In contrast to Horswill et al. (1988),
McNaughton found no effect of 0.1 g·kg-1 on pH or HCO3- concentrations. However,
McNaughton (1992) did find that dosages of 0.2, 0.3, 0.4, and 0.5 g·kg-1 significantly
elevated pH and HCO3-. Doses of 0.3 g·kg-1 and above increased peak power output, but
there was no additional increase beyond the 0.3 g·kg-1 dose.

Table 1
Summary of Studies Examining the Effects of NaHCO3 Supplementation on High-Intensity Intermittent Exercise
Author

Participants

Supplementation
-1

Dosage Timing

Exercise Protocol

Performance Results

Costill et al.
(1984)

10 males, 1
female; age =
32.4 years

0.2 g·kg NaHCO3 in 400 ml
solution consumed over 5-minute
period; 1 g NaCl placebo

60 minutes prior to
exercise testing

4 x 60-second cycling
bouts; 60-second rest
periods between bouts;
performance test: 5th cycling
bout to fatigue

Performance test time to
fatigue increased by 47
seconds (42% increase)

McKenzie et
al. (1986)

6 male athletes;
age = 22 ± 1.6
years

0.3 g·kg-1 NaHCO3 or 0.15 g·kg-1
NaHCO3 in 400 ml solution;
placebo (no details)

60 minutes prior to
exercise testing

5 x 60-second cycling
bouts; 60-second rest
periods between bouts;
performance test: 6th cycling
bout to fatigue

Both NaHCO3 trials
increased work output and
performance trial time, with
no significant difference
between trials

ParryBillings and
MacLaren
(1986)

6 healthy male
participants; no
age data
presented

0.3 g·kg-1 NaHCO3 or 0.3 g·kg-1
Na-citrate or 0.3 g·kg-1 NaHCO3/
Na-citrate ingested in a flavored
soup over 5- to 10-minute period;
NaCl placebo

150 minutes prior to
exercise testing

3 x 30-second maximal
cycling sprits; 6-minute rest
period between sprints

No increase in sprint
performance; trend was
present for elevated peak and
mean power

Maughan et
al. (1986)

10 physically
active males; age
= 27 ± 5 years

0.3 g·kg-1 NaHCO3 (alkalosis),
NH4Cl (acidosis), or CaCO3
(control); consumed in 1-2 gram
doses over 150-minute period;
water consumed ad libitum

Exercise testing
commenced
approximately 180
minutes after first
dose

Sustained knee extensor
MVC percentages (80%,
50%, 20%) to failure; 5minute rest periods between
sustained contractions

Alkalosis increased muscular
endurance capacity at 20%
MVC; acidosis decreased
endurance capacity at 50%
and 20% MVC
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Table 1 (continued).
Author

Participants

Supplementation

Dosage Timing

Exercise Protocol

Performance Results

Gao et al.
(1988)

10 male collegiate
swimmers; age =
20 ± 0.5 years

2.9 mmol/kg NaHCO3 (~0.24
g·kg-1) dissolved in 300 ml
solution; 17 mmol NaCl (~1 g)
placebo

Approximately 73
minutes prior to exercise
testing

5 bouts of maximal front crawl
swimming; 2-minute rest
periods between bouts

Bouts 4 and 5 were
significantly faster

Lavender
and Bird
(1989)

8 healthy females;
15 healthy males;
ages 18-28

0.3 g·kg-1 NaHCO3 in 400 ml
solution; 8 g NaCl placebo

200 ml of solution 120
minutes pre trial;
remaining 200 ml 60
minutes pre trial

10 x 10-second maximal
cycling sprints; 50-second rest
period between sprints

Increase in average
power and peak power
values

Gaitanos et
al. (1991)

7 healthy males;
age = 24.0 ± 1.9
years

0.3 g·kg-1 NaHCO3 in 500 ml
solution; consumed over 10
minutes; 1.5 g NaCl placebo

150 minutes prior to
exercise testing

10 x 6-second maximal sprints
on non-motorized treadmill

Trend for higher mean
and peak power output
and work done, but
results not significant

Webster et
al. (1993)

6 resistancetrained males; age
= 19.7 ± 0.5 years

0.3 g·kg-1 NaHCO3 in gelatin
capsules taken in single bolus;
water consumed ad libitum;
white flour placebo

105 minutes prior to
exercise testing

4 sets of 12 repetitions at 70%
1-RM on leg press exercise; 5th
set to muscular failure at 70% 1RM; 90-second rest periods
between sets

4 of 6 participants
increased repetitions in
5th set, but results not
significant
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Table 1 (continued).
Author

Participants

Supplementation
-1

Dosage Timing

Exercise Protocol

Performance Results

Coombes and
McNaughton
(1993)

9 recreationally
active males; age =
21.2 ± 2.6 years

0.3 g·kg NaHCO3 in 400 ml of
low caloric liquid; 0.3 g·kg-1
CaCO3 placebo

Approximately 90
minutes prior to
exercise testing

2 sets of isokinetic leg
extension/flexion; set 1 = 4
repetition strength; set 2 = 60
repetition endurance; rest = 5
minutes between sets

Increase in total work
and peak torque

Kozak-Collins
et al. (1994)

7 competitive female
cyclists acclimatized
to elevation; age =
26 ± 3 years

0.3 g·kg-1 NaHCO3 in 8-13
gelatin capsules; consumed
over 15-minute period; water
consumed ad libitum; 0.207
g·kg-1 NaCl placebo

120 minutes prior
to exercise testing

1-minute cycling sprints at 95%
VO2max; 1- minute rest between
sprints; sprints continued until
participant could not complete a
full 1-minute sprint; testing was at
moderate altitude

Completed more total
intervals, but results
not significant

Verbitsky et al.
(1997)

6 recreationally
active males; age =
36.5 ± 6 years

0.4 g·kg-1 NaHCO3 during
experimental condition only

60 minutes prior to
exercise testing

Pre-load: e-stim isometric
quadriceps contractions for 2
minutes; 3-minute supra-maximal
loading on cycle ergometer; 3minute rest periods; Post-load:
repeat pre-load

Increased post-load
peak torque and residual
torques

Portington et
al. (1998)

15 resistance-trained
males; age = 21.5 ±
0.4 years

0.3 g·kg-1 NaHCO3 in gelatin
capsules consumed in 5-minute
period; water consumed ad
libitum; white flour placebo

105 minutes prior
to exercise testing

5 sets of leg presses at
approximately 12-RM; 90second rest periods between sets

7 of 15 participants
increased total
repetitions, but results
not significant
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Table 1 (continued).
Author

Participants

Supplementation
-1

-

Dosage Timing

Exercise Protocol

Performance Results

Aschenbach et
al. (2000)

8 male collegiate
wrestlers; age =
20.6 ± 0.8 years

0.3 g·kg NaHCO3 or 0.21 g·kg
1
NaCl in 0.2 molar low-calorie
drink; low-calorie drink (no salt
added) placebo

Equal volumes of
solution consumed
90 and 60 minutes
prior to exercise
testing

8 x 15-second maximal arm
ergometry bouts; 20-second
freewheel pedaling recovery
periods between bouts

No differences seen in
peak power or total
work

McNaughton
et al. (2000)

6 males, 2 females;
age = 22.5 ± 1.15
years

0.5 g·kg-1 NaHCO3 contained in
gelatin capsules; divided into 4
doses per day

Chronic dosing for 5
days; exercise testing
took place on the 6th
day

3 x 30-second maximal cycling
sprints

Increased total work
output (sprints 1 and 2)
and peak power output
(sprints 1 and 2)

Price et al.
(2003)

8 moderatelytrained males; age =
25.4 ± 6.4 years

0.3 g·kg-1 NaHCO3 drink; 0.045
g·kg-1 NaCl placebo

60 minutes prior to
exercise testing

10 x 3-minute blocks on cycle
ergometer: 90-seconds at 40%
VO2max; 60-seconds at 60%
VO2max; maximal sprint; 14second active recovery

Power output was
maintained at a level
similar to the initial
stages of exercise

Bishop et al.
(2004)

10 recreationallyactive females; age
= 19 ± 1 years

0.3 g·kg-1 NaHCO3 contained in
8-14 gelatin capsules; consumed
with 500 ml of water 0.207 g·kg1
NaCl placebo

90 minutes prior to
exercise testing

5 x 6-second maximal sprints on
cycle ergometer; 24-second rest
period between sprints

Increased total work and
peak power output,
primarily during sprints
3-5
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Table 1 (continued).
Author

Participants

Supplementation
-1

Dosage Timing

Exercise Protocol

Performance Results

Bishop
and
Claudius
(2005)

7 team-sport
female athletes;
age = 19 ± 1
years

2 x 0.2 g·kg NaHCO3 contained
in 15-30 gelatin capsules;
consumed water ad libitum; 0.138
g·kg-1 NaCl placebo; participants
also consumed 3 x 150 ml water
and 3 x 150 ml carbohydrate
solution during testing

90 and 20 minutes pre
intermittent sprint
testing; each dose
consumed over 30
minutes (e.g. first dose
consumed 110-90 min
pre-exercise)

Intermittent sprint test
comprised of 2-minute blocks:
4-second maximal sprints; 100second active recovery; 20second passive rest; also
contained 2 repeated sprint
bouts: 5 x 2- seconds with 18second rest periods

Total work output and
peak power tended to
increase during 2nd half of
the sprint test, but results
not significant

Edge et al.
(2006)

16 moderately
trained females;
age = 19 ± 1
years

2 x 0.2 g·kg-1 NaHCO3 consumed
during training; 0.1 g·kg-1 NaCl
placebo

90 and 30 minutes before
each interval training
session

Interval training: 3x/week for 8
weeks; 6-12 sprint intervals of
2 minutes ranging from 91110% VO2peak; 1-minute rest
periods between sprints; Time
to fatigue test: 4-minute
unloaded cycling followed by
cycling to exhaustion

Alkalosis training resulted
in greater improvements
in lactate threshold and
short-term endurance
performance

Matsuura
et al.
(2007)

8 recreationallytrained males;
age = 20.8 ± 2.1
years

0.3 g·kg-1 NaHCO3 wrapped in
wafers capsules; divided into 6
doses consumed every 10 minutes
with 350 ml of water; 0.3 g·kg-1
CaCO3 placebo

Exercise testing began
approximately 120
minutes after first dose
and 60 minutes after last
dose

10 x 10-second maximal
cycling sprints; 30-second
passive recovery periods
between 8 sprints; 360-second
passive recovery period
between 2 sprints

No effect on performance
or surface EMG activity;
6 of 8 participants did
increase mean power
output during 9th sprint,
but results not significant
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Table 1 (continued).
Author

Participants

Supplementation

Dosage Timing

Exercise Protocol

Performance Results

-1

Artioli et
al. (2007)

23 experienced judo
competitors; Protocol
1—9 participants; age =
21.5 ± 3 years; Protocol
2—14 participants; age =
19.3 ± 2.4 years

0.3 g·kg NaHCO3 in
gelatin capsules; water
consumed ad libitum; 0.3
g·kg-1 CaCO3 placebo

120 minutes
prior to exercise
testing

Protocol 1—Special Judo Fitness
Test: 3 x 3 tests (test = 15-second,
30-second, and 30-second activity
periods with 10-second rest between
periods); 5-minute rest periods
between tests; Protocol 2—Wingate
for upper limbs: 4 x 30-second
maximal arm cycling bouts; 3minute rest periods between bouts

Protocol 1—Increase in total
number of throws (significant in
tests 2 and 3); Protocol 2—
Increase in relative mean power
(significant in bouts 3 and 4) and
relative peak power (significant
in bout 4)

Materko
et al.
(2008)

11 strength-trained
males; age = 23 ± 2.7
years

0.3 g·kg-1 NaHCO3
dissolved in water; 0.045
g·kg-1 NaCl placebo

120 minutes
prior to exercise
testing

10-RM bench press and pull press
tests

No performance enhancement

Zajac et
al. (2009)

8 competitive youth male
swimmers; age = 15 ±
0.4 years

0.3 g·kg-1 NaHCO3
dissolved in 500 ml
solution; consumed over
15- minute period;
equimolar NaCl placebo

90 minutes
prior to exercise
test

4 x 50 meter maximal front crawl
swims; 1-minute passive rest period
between swims

Increased completion time of
swimming test; swim 1 was
significantly faster; swims 3 and
4 were faster, but results not
significant
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Table 1 (continued).
Author

Participants

Supplementation
-1

Dosage Timing

Exercise Protocol

Performance Results

Siegler and
Hirscher
(2010)

10 trained boxers;
age = 22 ± 3 years

0.3 g·kg NaHCO3 dissolved
in 500 ml low-calorie solution;
consumed over 15-minute
period; 0.045 g·kg-1 NaCl
placebo

Approximately 6570 minutes prior to
exercise testing

4 x 3-minute boxing rounds; 1-minute
seated rest period between rounds

Increased punch
efficacy

Tan et al.
(2010)

12 female elite
water polo
players; age =
23.7 ± 3 years

0.3 g·kg-1 NaHCO3 consumed
with 600 ml of water over 10minute period; corn flour
placebo

90 minutes prior to
exercise testing

8 x 5-minute exercise blocks simulating
water polo match; 2-, 3-, and 5-minute
rest periods between blocks

No effect on water
polo match
performance

60 minutes prior to
exercise testing

20 x 24-second runs at 100% VO2max
(4
exercise bouts x 5 runs per bout); 36second rest periods between runs 1-4 in
each bout; 60-second rest period between
bouts; Performance test—4th bout, run at
120% VO2max to exhaustion

No improvement in
performance time or
distance covered
during the
performance test

(120 minutes prior to
exercise—pre-exercise meal
containing 1.5 g·kg-1
carbohydrate and 600 ml of
Gatorade)
Price and
Simmons
(2010)

8 male
intermittent-sport
athletes; age =
20.3 ± 1.0 years

0.3 g·kg-1 NaHCO3 dissolved
in 500 ml low-calorie solution;
consumed over 5-minute
period; 0.045 g·kg-1 NaCl
placebo
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Table 1 (continued).
Author
Cameron et
al. (2010)

Participants
25 elite male
rugby players; age
= 21.6 ± 2.6 years

Supplementation
-1

0.3 g·kg NaHCO3 dissolved in
500 ml isotonic sports drink;
0.045 g·kg-1 NaCl placebo
(consumed 30-minutes after
standardized snack)

Dosage Timing

Exercise Protocol

Performance Results

65 minutes prior to
rugby-specific
warm-up/training;
~100 minutes prior
to rugby-specific
repeated sprint test
(RSRST)

Rugby-specific exercise protocol
consisting of 25-minute warm-up
followed by 9-minute skill drills;
RSRST: 10 x 40-meter maximal sprints;
30-second rest periods between sprints

No effect on mean
sprinting performance
in RSRST

Wu et al.
(2010)

9 male collegiate
tennis players; age
= 21.8 ± 2.4 years

(1) 0.3 g·kg-1 NaHCO3 in 250
ml water; 0.209 g·kg-1 NaCl
placebo; (2) after 3rd tennis
game: 0.1 g·kg-1 NaHCO3 in
100 ml water; 0.07 g·kg-1 NaCl
placebo

(1) 70 minutes
prior to skill test 1;
~115 minutes prior
to skill test 2; (2)
~35 minutes prior
to skill test 2

20-minute tennis skill test (TST1)
followed by 50-minute simulated tennis
match comprised of 12 games; tennis
skill test repeated (TST2) after match

Significantly less
decline in service and
forehand stroke
consistency from
TST1 to TST2

Siegler and
GleadallSiddall
(2010)

6 male trained
swimmers; 8
female trained
swimmers; no age
data presented

0.3 g·kg-1 NaHCO3 dissolved in
500 ml low-calorie solution;
consumed over 15-minute
period; 0.045 g·kg-1 NaCl placebo

150 minutes prior
to exercise testing

8 x 25-meter front crawl maximal
sprints; 5 seconds of recovery between
sprints

2% decrease in total
swim time

Wahl et al.
(2010)

11 male athletes;
age = 26.5 ± 5.6
years

0.3 g·kg-1 NaHCO3 suspended
in 0.2 ml/kg water; CaCO3
placebo

Consumed over 90minute period prior
to exercise testing

4 x 30-second maximal cycle sprints; 5
minutes of recovery between sprints

Increase in mean
power during 3rd and
4th sprints
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Other researchers have examined the dose-related effects relative to more prolonged, or
chronic, NaHCO3 supplementation. Dourodous et al. (2006) investigated the effects of
five days of supplementation with amounts equaling 0.3 g·kg-1·day-1 or 0.5 g·kg-1·day-1.
The authors found that both doses elevated pH and HCO3-, but there was no significant
difference between the two doses. McNaughton et al. (2000) conducted a similar study
using only 0.5 g·kg-1·day-1, but in this case, the authors examined changes in pH and
HCO3- after every day of supplementation. While pH and HCO3- were elevated after each
dose, there was no additive effect, with the values peaking after the first day of
supplementation. In a more recent study, Siegler et al. (2009) investigated the timecourse effects of various NaHCO3 dosages. After administering doses of 0.1, 0.2, or 0.3
g·kg-1, the authors found that blood buffering capacity was significantly increased only
after doses of 0.2 and 0.3 g·kg-1, with no differences between the two dosages.
The HIE studies utilized dosages ranging from 0.15 g·kg-1 (McKenzie et al., 1986)
to 0.5 g·kg-1 (McNaughton et al., 2000). In agreement with Horswill et al. (1988),
McKenzie et al. (1986) found that a dose of 0.15 g·kg-1 significantly elevated pH and
HCO3-. In the same study, the authors also administered 0.3 g·kg-1. While the higher
dosage resulted in higher extracellular pH and HCO3-, there was no statistically
significant difference between doses. The authors concluded that a dose of 0.15 g·kg-1
was adequate to enhance blood buffering capacity and performance (McKenzie et al.,
1986). While recent evidence suggests that a dosage as low as 0.1 g·kg-1 can enhance
blood buffering capacity (Siegler et al., 2009), past research suggests doses this low are
not beneficial to performance (McNaughton, 1992). However, McNaughton (1992)
examined one bout of high-intensity exercise, whereas McKenzie et al. (1986) utilized a
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repeated-bouts protocol. Research indicates that repeated bouts of high-intensity exercise
generate a larger pH gradient than continuous exercise due to the accumulation of
intracellular H+ (Hermansen & Osnes, 1972; Matson & Tran, 1993). This pH gradient,
potentiated by 0.15 g·kg-1 NaHCO3 administration, may be why McKenzie et al. (1986)
found significant improvement in performance. The vast majority (~79%) of HIE
studies, however, administered doses of 0.3 g·kg-1. All of the studies utilizing this
amount found significant increases in blood buffering capacity, when measured. For
example, Siegler and Hirscher (2010) found that a dose of 0.3 g·kg-1 elevated resting
blood pH from 7.37 to 7.43 units, HCO3- from 23.9 to 29.0 milliequivalents per liter
(mEq·l-1), and base excess (BE) from -0.03 to 5.7 mEq·l-1. BE is another measure of
blood buffering capacity, with negative values indicating a more acidic environment and
positive values indicating a more alkaline environment (Andersen & Engel, 1960).
Similar to Siegler and Hirscher (2010), Webster et al. (1993) found that NaHCO3
administration increased pH from 7.39 to 7.46 units, HCO3- concentration from 22.9 to
28.2 mEq·l-1, and BE from -1.3 to 4.4 mEq·l-1. As previously noted, statistically
significant increases in pH are typically in the range 0.05 to 0.1 units, while significant
increases in HCO3- concentration are in the range of 5 to 6 mEq·l-1 (Webster, 2002).
While most of the HIE studies only analyzed extracellular (i.e., blood) variables,
Bishop et al. (2004) examined intramuscular pH (pHi) as well. The researchers found that
resting pHi was not affected by an alkalizing agent (pHi placebo = 7.12, pHi NaHCO3 =
7.11). These results are in agreement with a recent non-HIE study. Forbes et al. (2005)
found that administering a dose of 0.3 g·kg-1 did not affect resting pHi (pHi placebo =
7.06, pHi NaHCO3 = 7.09). The results of these studies are consistent with the idea that
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the sarcolemma is not readily permeated by extracellular HCO3- (Coombes &
McNaughton, 1993). Therefore, there appears to be no buffering effects of an elevated
HCO3- reserve at rest when the pH gradient is minimal (Bishop et al., 2004). The
ergogenic potential of NaHCO3 supplementation appears to be greatest when the pH
gradient is maximized by an elevated HCO3- reserve and excessive intracellular H+
production. This concept is exemplified by an interesting study conducted by Maughan et
al. (1986). In addition to administering NaHCO3 to induce alkalosis, the authors also
administered ammonium chloride (NH4Cl) to induce a state of acidosis. NH4Cl
administration resulted in significant decreases in pH (from 7.37 to 7.26), HCO3concentration (from 24.4 to 16.8 mEq·l-1), and BE (from 0.2 to -8.6 mEq·l-1). Conversely,
NaHCO3 supplementation resulted in significant increases in pH (from 7.39 to 7.42),
HCO3- (from 24.1 to 27.0 mEq·l-1), and BE (0.0 to 3.5 mEq·l-1). The authors found that
alkalosis enhanced isometric endurance capacity at low muscular tension, while acidosis
inhibited endurance capacity. This suggests that the reduction in extracellular pH reduced
the efflux of lactate and H+ from the cell, ultimately accelerating the exercise-induced
decrease in pHi and onset of fatigue (Maughan et al., 1986). It appears that all of the HIE
NaHCO3 dosages examined in this review can enhance blood buffering capacity by
elevating pH and HCO3- reserve. With this being the case, whether there is a strong
enough pH gradient to facilitate H+ efflux seems dependent upon the exercise protocol.
Of the 23 studies that utilized 0.3 g·kg-1 NaHCO3, 12 found significant ergogenic
effects of supplementation (see Table 1 for Performance Results). An additional six
studies indicated potential for performance enhancement, but the results of those studies
were not statistically significant (Gaitanos et al., 1991; Kozak-Collins et al., 1994;
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Matsuura et al., 2007; Parry-Billings & MacLaren, 1986; Portington et al., 1998; Webster
et al., 1993). Only five of the 0.3 g·kg-1 studies indicated no trend toward performance
enhancement (Aschenbach et al., 2000; Cameron, McLay-Cooke, Brown, Gray, &
Fairbairn, 2010; Materko et al., 2008; Price & Simmons, 2010; Tan et al., 2010). Some of
the methodology of these studies, which will be discussed below, may have accounted for
the lack of ergogenic evidence. Other NaHCO3 doses of 0.2 g·kg-1 (Costill et al., 1984),
0.24 g·kg-1 (Gao et al., 1988), 0.4 g·kg-1 (Edge et al., 2006; Verbitsky et al., 1997), and
0.5 g·kg-1 (McNaughton et al., 2000) all demonstrated ergogenic effects, with such
performance enhancements as a 42% increase in cycling time to fatigue (Costill et al.,
1984) and significantly faster swimming bouts (Gao et al., 1988).
Timing of administration. Another confounding variable that often makes the
results of NaHCO3 studies difficult to interpret is timing of administration. Even within
the specific realm of HIE studies, there is wide variability in the timing of administering
the NaHCO3 dose. Historically, the time period for completely ingesting the supplement
has ranged from an “all at once” dose, to an ingestion period spanning three hours
(Matson & Tran, 1993). The time between completion of ingestion and initiation of
exercise testing has been equally as variable, with acute supplementation being
completed anywhere from immediately before exercise to three hours before exercise
(Matson & Tran, 1993). In fact, chronic dosing schemes may be completed the day
before exercise testing (McNaughton et al., 2000). To elucidate the appropriate timecourse for NaHCO3 administration, Renfree (2007) examined extracellular H+
concentrations at various times following administration of 0.3 g·kg-1, divided into three
equal doses consumed every 15 min. The author found that the greatest decrease in H+
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concentration (and consequent increase in pH) occurred between 60 and 90 min post
ingestion. Also of interesting note is the fact that, by 150 min, there was no significant
difference between the NaHCO3 or placebo groups in terms of extracellular H+
concentration, although the pH of the NaHCO3 group remained higher until 180 min post
ingestion (Renfree, 2007). A more recent study by Siegler et al. (2009) is in agreement
with, and builds upon, the results obtained by Refree (2007). For dosages of 0.2 and 0.3
g·kg-1, the authors determined that peak blood buffering capacity occurred at
approximately 45 and 65 min, respectively (Siegler et al., 2009). In the same study,
Siegler et al. (2009) also compared chronic dosing to acute dosing, and determined that
acute dosing was superior to chronic dosing, in terms of the timing associated with
establishing the necessary pH gradient to enhance performance.
The selected HIE studies have wide variability in the timing of administration,
with completion of acute ingestion ranging from 60 to 150 min prior to exercise testing.
Only six of the studies (Aschenbach et al., 2000; McKenzie et al., 1986; Price et al.,
2003; Price & Simmons, 2010; Siegler & Hirscher, 2010; Verbitsky et al., 1997) initiated
exercise testing during the time frame in which Siegler et al. (2009) suggested peak blood
buffering occurred. HIE or prolonged interval exercise results in a gradual, yet
substantial, H+ accumulation over the course of the intervals (Hermansen & Osnes, 1972;
Matson & Tran, 1993). This is likely the reason why the ergogenic potential for NaHCO3
supplementation demonstrated by HIE studies often occurs during the later bouts of
exercise (Artioli et al., 2007; Bishop et al., 2004; Maughan et al., 1986; McKenzie et al.,
1986; Price et al., 2003; Wahl, Zinner, Achtzehn, Bloch, & Mester, 2010; Zajac et al.,
2009). This means that many of the HIE studies have possibly utilized protocols that
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produced the greatest H+ accumulation during the time frame in which blood buffering
potential was already tapering. For example, Bishop and Claudius (2005) examined the
effects of NaHCO3 administration on a prolonged HIE task comprised of two 36-min
sessions. While the authors did not find any significant performance effects, they did note
a trend toward enhanced performance during the second session. The supplementation
protocol involved two doses of 0.2 g·kg-1, with the first dose being consumed 90 min
prior to exercise and the second dose being consumed 20 min prior to exercise testing
(Bishop & Claudius, 2005). Based on the work of Siegler et al. (2009), this suggests that
peak pH and HCO3- levels occurred at the beginning of the second session, which began
approximately one hour after completion of ingestion. Given that the second session
lasted 36 min (Bishop & Claudius, 2005), it is probable that blood buffering capacity was
tapering, as shown by Siegler et al. (2009), during the time of excessive H+ production.
This demonstrates the importance of appropriate timing of administration of NaHCO3. If
too much time lapses between completion of ingestion and exercise, ergogenic potential
may be reduced. This is also possibly the case in the study conducted by Parry-Billings
and MacLaren (1986). The researchers administered NaHCO3 approximately 150 min
prior to exercise testing. Subsequently, the researchers found that, although a trend was
present for enhanced performance, the results were not statistically significant (ParryBillings & MacLaren, 1986). This seems to be in line with the study by Renfree (2007)
which found there were no significant pH differences between NaHCO3 or placebo
supplementation at 150 min post-ingestion.
Placebo. Along with the confounding variables of dosage and timing, the placebo
utilized should be carefully considered. The three placebos administered in HIE studies
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were NaCl, calcium carbonate (CaCO3), and flour (see Table 1 for Supplementation).
Although the majority (~62%) of the studies used NaCl as a placebo, previous research
suggests that NaCl may not be physiologically inert (Bishop et al., 2004). Along these
lines, Lavender and Bird (1989) found that NaCl administration alone enhanced cycling
sprint performance. Researchers have postulated that the increase in extracellular Na+
concentration accompanying NaCl administration may confer ergogenic effects through
increased plasma volume and tissue perfusion (Mitchell et al., 1990), elevated H+ efflux
due to upregulation of the Na+/ H+ exchanger (Bishop et al., 2004), or elevated
extracellular HCO3- concentration due to disturbances in strong ion equilibrium
(Heigenhauser & Jones, 1991). Aschenbach et al. (2000) conducted a study to examine
the effects on performance of equimolar amounts of Na+ from either NaHCO3 or NaCl.
The researchers found that NaCl had no effect on pH or performance, relative to a lowcalorie beverage placebo (Aschenbach et al., 2000). To avoid the potential physiological
effects of NaCl, researchers have used a CaCO3 placebo. In general, NaHCO3 studies that
have used CaCO3 as a placebo have tended to find significant ergogenic effects, more so
than those studies using large NaCl dose placebos (Linderman & Fahey, 1991). However,
only five of the HIE studies utilized CaCO3 placebos (Artioli et al., 2007; Coombes &
McNaughton, 1993; Matsuura et al., 2007; Maughan et al., 1986; Wahl et al., 2010). Of
these studies, only one did not find a significant ergogenic effect for NaHCO3, although
there was a trend for enhanced performance (Matsuura et al., 2007). There was large
variability in NaCl doses for those studies using NaCl as the placebo. Dosages ranged
from as little as one gram of NaCl (Costill et al., 1984), to as large 0.21 g·kg-1
(Aschenbach et al., 2000), which would equate to approximately 15 grams of NaCl for
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the average participant. Based on supplementation protocols alone, there is no apparent
trend among the HIE studies indicating a superior dosage of NaCl, in terms of
establishing ergogenic effects for NaHCO3 administration. Although past research
suggests that lower NaCl doses, when compared to higher doses, are more highly
correlated with NaHCO3 ergogenic effects (Linderman & Fahey, 1991), this trend is not
seen when examining the selected HIE studies. NaCl placebo doses as low as 1.5 grams
(Gaitanos et al., 1991) and 0.045 g·kg-1 (Materko et al., 2008) were not associated with
ergogenic effects of NaHCO3, while NaCl doses as high as 8 grams (Lavender & Bird,
1989) and 0.207 g·kg-1 (Bishop et al., 2004) were utilized in studies that demonstrated
alkalosis-induced performance enhancements. None of the HIE NaHCO3 studies using a
flour placebo demonstrated an ergogenic effect (Portington et al., 1998; Tan et al., 2010;
Webster et al., 1993), although it is unlikely that the results of these studies were strongly
affected by placebo.
Side effects and administration details. The typical NaHCO3 dose of 0.3 g·kg-1
equates to 21 grams of NaHCO3 for the 70 kg athlete. Consuming dosages this large can
increase the osmolality of the gastrointestinal (GI) tract (Requena et al., 2005). This
increase in solute concentration in the gut can draw water from the plasma back into the
GI tract to create an isotonic solution (Linderman & Gosselink, 1994; Webster, 2002).
This influx of water can lead to symptoms such as GI discomfort, diarrhea, cramps, and
bloating (Linderman & Gosselink, 1994). Cameron et al. (2010) detailed the GI distress
symptoms experienced by 25 elite rugby players after consumption of 0.3 g·kg-1
NaHCO3. Commonly reported symptoms included nausea, flatulence, stomach cramping,
belching, stomachache, bowel urgency, diarrhea, vomiting, and stomach bloating.
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Interestingly, even though the participants experienced significantly greater GI distress
with NaHCO3 when compared to placebo, the participants reported lower ratings of
perceived exertion (RPE) during the NaHCO3 condition (Cameron et al., 2010). To
prevent GI distress, researchers have tried various alterations in the supplementation
protocol, such as administering doses with large volumes of fluid (e.g., 500-2000 ml) and
dividing dosages into smaller amounts consumed in increments (Burke & Pyne, 2007).
Interestingly, Heigenhauser and Jones (1991) have reported that large volumes of water,
up to 1.5 l, not only decrease the potential for GI disturbances, but also enhance alkalosis.
Very few of the HIE studies commented on side effects of supplementation, with only
five studies reporting any negative effects (Cameron et al., 2010; Kozak-Collins et al.,
1994; Price & Simmons, 2010; Siegler & Hirscher, 2010; Webster et al., 1993). Reported
fluid consumption ranged from 300 ml (Gao et al., 1988) to 2.1 l (Matsuura et al., 2007),
although not all of the studies detailed fluid intake (see Table 1 for Supplementation).
The most commonly recorded amounts of fluid consumption were 400 ml (Coombes &
McNaughton, 1993; Costill et al., 1984; Lavender & Bird, 1989) and 500 ml (Bishop et
al., 2004; Cameron et al., 2010; Gaitanos et al., 1991; Price & Simmons, 2010; Siegler &
Gleadall-Siddall, 2010; Siegler & Hirscher, 2010; Zajac et al., 2009), which is
substantially less than the 1.5 l recommended by Heigenhauser and Jones (1991). Several
researchers allowed fluid to be consumed ad libitum (Artioli et al., 2007; Bishop &
Claudius, 2005; Kozak-Collins et al., 1994; Maughan et al., 1986; Portington et al., 1998;
Webster et al., 1993; Wu et al., 2010), with only Portington et al. (1998) and Wu et al.
(2010) measuring ad libitum fluid intake (~1.4 and 1.1 l, respectively).
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With fluid intake exerting important effects on alkalinizing capacity and GI
distress prevention, it appears that fluid consumption should be more tightly regulated.
The same could be said of incremental NaHCO3 dosage administration. Most HIE
researchers attempted to break the dosages into smaller amounts by either allowing a
certain time frame for consumption or by employing a stacking method of consumption.
The most commonly reported intervals for supplement consumption were 5- to 15-min
periods (see Table 1), while incremental ingestion periods as high as 50 min (Matsuura et
al., 2007) and 150 min (Maughan et al., 1986) were also utilized. Several studies
employed what Siegler et al. (2009) refer to as a “stacking” protocol. This type of
protocol is exemplified in the study by Aschenbach et al. (2000). The researchers
administered supplementation in two equal doses at 90 and 60 min prior to exercise. This
method was effective in enhancing blood buffering capacity and preventing GI distress
(Aschenbach et al., 2000). Since all of the HIE supplementation methods resulted in
enhanced blood buffering capacity, it seems logical that the method selected should focus
on appropriate timing, while attempting to prevent GI disturbances. In attempt to bypass
the gut, and therefore eliminate the risk of GI disturbances, investigators have infused
NaHCO3 intravenously (Granier et al., 1996; Wijnen, Verstappen, & Kuipers, 1984).
Although NaHCO3 infusion has improved HIE performance (Wijnen et al., 1984), this
method is impractical in most field or competitive settings. The more practical practice of
oral administration has been implemented in a variety of ways, such as dissolving
NaHCO3 in water (Materko et al., 2008), a flavored low-calorie beverage (Aschenbach et
al., 2000), or soup (Parry-Billings & MacLaren, 1986), and by administration through
gelatin capsules (Bishop et al., 2004; Webster et al., 1993). With regard to enhancing the
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blood buffering capacity, there appears to be no difference in NaHCO3 administration
through fluids or capsules (Matson & Tran, 1993).
NaHCO3 supplementation summary. NaHCO3, more commonly known as baking
soda, is a sodium salt that has commonly been administered to induce alkalosis.
Historically, the typical administered dosage has been 0.3 g·kg-1. This holds true for HIE
research, with the majority of the selected studies utilizing this dose, although doses
ranging from as little as 0.15 g·kg-1 to as much as 0.5 g·kg-1 have been reported. All HIE
NaHCO3 dosages elevated blood buffering capacity, as evidenced by an increase in
extracellular pH, HCO3- reserve, and BE. In addition to supplementation amount, three
other important factors to consider when dosing with NaHCO3 are timing of
administration, placebo, and side effects. Evidence suggests that peak plasma levels of
pH and HCO3- occur approximately 60 min after ingestion. If this is the case, then many
of the HIE studies failed to capitalize on peak buffering capacity since most of the studies
initiated exercise testing more than 60 min after ingestion. NaCl was the most commonly
used placebo for the HIE studies, even though some research indicates that this placebo is
not physiologically inert. CaCO3 is an alternative placebo that does not exert any effect
on buffer capacity or performance and was used in a small number of the HIE studies.
Lastly, GI distress can result from NaHCO3 supplementation due to the concentrated load
imposed on the gut. To contend with this side effect, researchers have administered
NaHCO3 in incremental doses with large volumes of water. Although the methodology
varied, this was the common practice in the selected HIE studies and was effective in
minimizing or preventing GI disturbances.

39
HIE Protocols and Performance Results
The studies selected for more extensive review were chosen because they utilized
exercise protocols that involved repeated bouts of high-intensity exercise interspersed
with brief rest periods. The major focus of this document is the potential ergogenic
benefit of NaHCO3 supplementation for HRE. Since relatively few studies have
examined the effect of induced alkalosis on resistance exercise, the details of various
types of HIE studies are included here to provide a more complete picture of the effects
of NaHCO3 administration on intense interval exercise. The HIE studies not only
employed variable supplementation methodology, but they also utilized a variety of
exercise protocols (see Table 1 for Exercise Protocol). In order to compare the different
protocols and performance results, the HIE studies have been placed in the following
groups based on exercise modality: cycling, running, swimming, sport-specific, and
resistance exercise.
Cycling. The most commonly used exercise mode to assess HIE was cycling, with
12 studies examining the effects of induced-alkalosis on cycle ergometry performance
(see Table 1). The cycling protocols can be further subdivided on the basis of brief (6-30
s), intermediate (60 s), and more prolonged (120-180 s) intervals. Bishop et al. (2004)
utilized the shortest cycling intervals to examine the effects of induced alkalosis on repeat
sprint ability. Using five, 6-s maximal sprint intervals interspersed with 24 s of recovery,
the authors found that NaHCO3 administration increased total work and peak power,
primarily during the later sprints (Bishop et al., 2004). Similar to these findings are those
presented by Lavender and Bird (1989). These researchers utilized a slightly longer
protocol, including ten, 10-s maximal sprints with 50-s rest periods between sprints.
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Lavender and Bird (1989) found that induced-alkalosis increased both peak and average
power, demonstrating the ergogenic potential of NaHCO3. Matsuura et al. (2007)
conducted a similar study to Lavender and Bird (1989), with the only difference
occurring in the rest interval times. The authors used rest periods of 30-s between most of
the sprint intervals, although two, 6-min rest periods were utilized during the protocol to
examine the effects of PCr repletion on subsequent performance. In contrast to the
previous studies (Bishop et al., 2004; Lavender & Bird, 1989), Matsuura et al. (2007) did
not find significant increases in performance. However, the authors did notice a trend of
increased power output during the ninth sprint of the NaHCO3 group. Parry-Billings and
MacLaren (1986) conducted a similar study to Matsuura et al. (2007) in that the authors
used 6-min rest periods and did not find an ergogenic effect. Parry-Billings and
MacLaren (1986), however, only used three, 30-s maximal sprint intervals. Although the
results were not significant, the authors did note a trend for increased peak and mean
power, as well (Parry-Billings & MacLaren, 1986). Whereas Parry-Billings and
MacLaren (1986) did not find significant results, McNaughton et al. (2000) did
demonstrate the ergogenic efficacy of NaHCO3 using a very similar protocol. The
researchers found that induced-alkalosis increased total work and peak power output in a
protocol that utilized three, 30-s maximal sprints (McNaughton et al., 2000). Along these
same lines, Wahl et al. (2010) also demonstrated ergogenic effects utilizing a protocol
involving four, 30-s maximal cycling sprints, interspersed with 5-min rest periods. The
investigators found that NaHCO3 administration significantly improved mean power
output during the third and fourth sprints (Wahl et al., 2010).
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Costill et al. (1984) conducted some of the pioneering research on HIE,
examining the effects of induced-alkalosis on intermediate-length sprint intervals. This
exercise protocol involved four, 60-s cycling bouts interspersed with 60-s rest periods. A
fifth cycling bout to fatigue was used as a performance test. The researchers found an
impressive 42% increase in time fatigue (Costill et al., 1984), with these results
stimulating interest in the ergogenic potential of NaHCO3 for interval protocols.
McKenzie et al. (1986) and Kozak-Collins et al. (1994) conducted very similar studies to
that of Costill et al. (1984), but with equivocal results. The findings of McKenzie et al.
(1986) are in agreement with those of Costill et al. (1984). The researchers found that two
levels of NaHCO3 administration improved a performance test proceeding five, 60-s
cycling bouts interspersed with 60-s rest periods (McKenzie et al., 1986). In contrast,
Kozak-Collins et al. (1994) did not find significant improvements in the number of 60-s
cycling intervals that could be completed at an intensity corresponding to 95% VO2max,
with 60-s rest periods between intervals. However, the authors did note that a trend
toward performance enhancement was apparent (Kozak-Collins et al., 1994).
The last three cycling protocols to be discussed utilized more prolonged sprint
intervals, lasting at least two minutes. Price et al. (2003) used a prolonged intermittent
protocol comprised of three, 10-min blocks at various intensities, ranging from 40%
VO2max to “all out” sprinting, with 14 s of active recovery between blocks. The authors
found ergogenic potential for NaHCO3, demonstrating that power output at the end of the
protocol was maintained at a similar level to that seen at the beginning (Price et al.,
2003). Similar, albeit insignificant, results were obtained by Bishop and Claudius (2005)
using a more prolonged protocol involving two, 36-min sessions designed to simulate the
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energy demands of field hockey. Although the protocol, which involved 2-min exercise
blocks, did not elicit significant performance enhancement for the NaHCO3 group, a
trend of improved performance was seen during the second 36-min session (Bishop &
Claudius, 2005). Lastly, Edge et al. (2006) conducted an interesting study to examine the
effects of induced-alkalosis on interval training. This protocol involved training three
times per week, for eight weeks, after NaHCO3 ingestion. Each training session involved
6-12 sprint intervals lasting two minutes each, with 60-s rest periods between sprints. The
authors found that training after induced-alkalosis ultimately resulted in an improvement
in lactate threshold and short-term endurance performance (Edge et al., 2006).
Running and swimming. Whereas a relatively large number of HIE studies utilized
cycling protocols, the modalities of running (Gaitanos et al., 1991; Price & Simmons,
2010) and swimming (Gao et al., 1988; Zajac et al., 2009) were much less common.
Gaitanos et al. (1991) examined the effects of NaHCO3 administration on short duration
maximal running. The results of this study, which involved 10, 6-s sprints on a nonmotorized treadmill, indicated that induced-alkalosis was not beneficial to this type of
performance. However, the authors did indicate that a trend for higher power outputs and
total work completed was seen in the alkaline condition (Gaitanos et al., 1991). Price and
Simmons (2010) conducted another HIE running study to examine the effects of NaHCO3
on a performance test that was preceded by repeated sprints. The repeated sprints
consisted of 20, 24-s runs at 100% VO2max, with variable rest periods between sprints.
Following the sprints, the researchers conducted a performance test that required running
until exhaustion at an intensity of 120% VO2max. There were no significant improvements
in performance test time to exhaustion or distance covered, suggesting that NaHCO3
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supplementation was not beneficial for this type of exercise task (Price & Simmons,
2010). Whereas these HIE running studies failed to demonstrate the ergogenic potential
of NaHCO3, previous studies have utilized induced-alkalosis to enhance running
performance. For example, Wilkes et al. (1983) and Goldfinch et al. (1988) utilized
racing protocols that, while not intermittent, still heavily taxed the glycolytic energy
system. Induced-alkalosis resulted in faster 400-meter (m) (Wilkes et al., 1983) and 800m (Goldfinch, McNaughton, & Davies, 1988) racing times. Taken together, this suggests
that the HIE running studies may not have used long enough running durations to create
significant acidosis.
Although previous studies investigating the effects of induced-alkalosis on
swimming can technically fall under the genre of HIE (Mero, Keskinen, Malvela, &
Sallinen, 2004; Pierce, Eastman, Hammer, & Lynn, 1992), only three swimming studies
(Gao et al., 1988; Siegler & Gleadall-Siddall, 2010; Zajac et al., 2009) were located that
involved protocols consistent with the other selected HIE methodology (i.e., short rest
periods). Gao et al. (1988) examined the effects of NaHCO3 on five bouts of nearmaximal, 100-yard front crawl swimming, interspersed with 2-min rest periods. The
authors found an ergogenic effect for supplementation, with the times to complete bouts
four and five being significantly faster in the NaHCO3 trial (Gao et al., 1988). Zajac et al.
(2009) utilized a similar, albeit shorter, protocol to that of Gao et al. (1988) and obtained
similar results. In order to examine the effects of NaHCO3 administration on the
swimming performance of youth athletes, the researchers used a protocol that required
four, 50-m (~55 yards) maximal, front crawl swims, with 60-s rest intervals between
bouts. Zajac et al. (2009) found that the time to complete the entire protocol was
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significantly faster in NaHCO3 trial. Similar to the results of Gao et al. (1988), there was
a trend for the third and fourth bouts to be faster, although only the first swimming bout
was significantly faster (Zajac et al., 2009). In a more recent HIE swimming study,
Siegler and Gleadall-Siddall (2010) established the ergogenic efficacy for inducedalkalosis on a protocol utilizing shorter sprint durations and rest periods than the previous
two studies. Participants completed eight maximal 25-m front crawls, with 5-s rest
periods interspersed between sprints. The authors found that NaHCO3 supplementation
resulted in a significant 2% decrease in total time required to complete all sprints (Siegler
& Gleadall-Siddall, 2010).
Sport-specific. Some of the more interesting methodology is that seen in those
HIE studies that can be classified as “sport-specific.” The elaborate cycling protocol of
Bishop and Claudius (2005), as detailed above, could have been placed into this
grouping, since the exercise protocol was designed to mimic the energy requirements of
field hockey. Recently, Tan et al. (2010) investigated the effects of NaHCO3 on a
simulated water polo match. The researchers utilized a protocol comprised of eight, 5min blocks of exercise similar to that experienced during a polo match, with rest periods
ranging from two to five minutes between blocks. The results of this study indicated that
that NaHCO3 was not an effective ergogenic aid for this type of exercise (Tan et al.,
2010). Similar to the results obtained by Tan et al. (2010), Cameron et al. (2010) found
that NaHCO3 supplementation was not beneficial to simulated rugby performance. The
methodology of this study required elite rugby players to complete a rugby-specific
repeated-sprint test following 34 min of rugby-specific warm-up and drills (Cameron et
al., 2010). In another recent sport-specific study, Siegler and Hirscher (2010) examined
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the effects of induced-alkalosis on boxing performance. A performance enhancing effect
was demonstrated as the boxers achieved greater punch efficacy over the course of the
protocol, which involved four, 3-min simulated boxing rounds (Siegler & Hirscher,
2010). Wu et al. (2010) also established ergogenic efficacy for NaHCO3 administration
before sport-specific testing. To assess the effect of NaHCO3 on tennis performance, the
researchers administered a tennis-specific skill test before and after a simulated tennis
game. Induced-alkalosis prevented a decline in tennis skill performance (Wu et al., 2010).
An ergogenic effect for NaHCO3 administration before sport-specific exercise testing was
demonstrated by Artioli et al. (2007), as well. These investigators examined the effects of
induced-alkalosis on Judo performance, utilizing a complex fitness test and arm
ergometry. The Judo fitness test involved three bouts of a simulated sparring exercise in
which the total number of successful throws were assessed. In the same study, the
researchers investigated arm ergometry performance with four, 30-s maximal cycling
bouts, interspersed with 3-min rest periods. Induced-alkalosis enhanced performance in
both of these protocols, resulting in more total throws during the fitness test and greater
relative mean and peak power during the arm ergometry (Artioli et al., 2007). Arm
ergometry was also the exercise mode chosen by Aschenbach et al. (2000) to assess the
effects of NaHCO3 administration on the performance of collegiate wrestlers. In contrast
to Artioli et al. (2007), Aschenbach et al. (2000) did not demonstrate the ergogenic
efficacy for induced-alkalosis during an exercise protocol that utilized eight, 15-s
maximal cycling bouts, interspersed with 20 s of active recovery.
Resistance exercise. The last HIE group, which is central to this review, includes
those studies examining the effects of NaHCO3 administration on resistance exercise

46
performance. In an early study, Maughan et al. (1986) examined the effects of inducedalkalosis on sustained contractions of the knee extensors. The protocol required
contractions until failure at varying percentages (20, 50, and 80%) of the maximal
voluntary contraction (MVC) capability, with 5-min rest periods between efforts. The
investigators found that alkalosis did enhance performance, but only during the 20%
MVC trial (Maughan et al., 1986). Coombes and McNaughton (1993) also demonstrated
the ergogenic potential of induced-alkalosis on resistance exercise. These researchers
assessed muscular endurance and strength of the leg extensors and flexors with two sets
of isokinetic exercise. The first set assessed 4-repetition strength, while the second set
examined 60-repetition endurance capacity. Study results demonstrated the efficacy of
NaHCO3 supplementation, indicating an increase in total work completed and peak
torque (Coombes & McNaughton, 1993). An interesting study by Verbitsky et al. (1997)
examined muscle fatigue and recovery using electrical stimulation (e-stim) and supramaximal cycling. The resistance aspect of this study involved isometric e-stim actions of
the knee extensors before and after three minutes of intense isotonic cycling. The authors
found that induced-alkalosis resulted in greater peak and residual torques following the
cycling bout, indicating that NaHCO3 administration delayed fatigue and improved
recovery between exercise sets (Verbitsky et al., 1997).
Webster et al. (1993) were the first to examine NaHCO3 supplementation on highvolume resistance exercise. This protocol required four sets of 12 repetitions of the leg
press exercise at 70% 1-RM, with 90 s of recovery between sets. A fifth set to muscular
failure with the same load was utilized as a performance test. The researchers found that,
although the results were not significant, there was a trend toward increased repetitions in
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the performance test (Webster et al., 1993). Portington et al. (1998) followed up the study
by Webster et al. (1993) with a very similar, yet more intense, protocol. In this study, five
sets of maximal leg presses (~12-RM) were utilized, with total repetitions completed
serving as the performance parameter. Similar to the previous results, Portington et al.
(1998) found a trend toward increased repetitions, although the results were not
significant. The most recent study examining the effects of induced-alkalosis on
resistance exercise does not fall under the HIE genre, per se. Materko et al. (2008)
assessed the effects of NaHCO3 administration on only one set of muscular strength
exercise. In contrast to Coombes and McNaughton (1993), the authors found that
supplementation did not improve strength, as evidenced by no performance increase in
the bench and pull press exercises at an intensity of 10-RM (Materko et al., 2008).
Efficacy of supplementation and methodological considerations. Of the selected
studies contained within this review, 17 found that NaHCO3 administration significantly
improved performance, while an additional seven indicated that there was a trend toward
elevated performance (see Table 1). This means that only five of the reviewed studies
failed to demonstrate any ergogenic potential for NaHCO3 supplementation (Aschenbach
et al., 2000; Cameron et al., 2010; Materko et al., 2008; Price & Simmons, 2010; Tan et
al., 2010). However, careful consideration of the methodologies of these studies may
provide insight into why performance was not enhanced.
Those HIE studies that did indicate improvements in performance utilized
methods that not only increased blood buffering capacity through supplementation, but
also likely created large pH gradients through excessive H+ production. The studies by
McKenzie et al. (1986) and Siegler and Hirscher (2010) exhibited exemplary methods for
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performance enhancement. Both studies utilized supplementation protocols that involved
ingestion of either 0.3 g·kg-1 NaHCO3 or small NaCl placebo approximately 60-70 min
prior to exercise testing, the time necessary to achieve peak blood buffering capacity
(Siegler et al., 2009). This enhanced capacity was evidenced by significant increases in
pH and HCO3- concentration. McKenzie et al. (1986) reported post-ingestion pH and
HCO3- values of 7.42 units and 27.9 mEq·l-1, respectively. Similarly, Siegler and Hirscher
(2010) reported post ingestion pH and HCO3- values of 7.43 units and 29.0 mEq·l-1,
respectively. These values represented significant increases above baseline levels. Both
of these studies also utilized exercise protocols that rely heavily on fast glycolysis, being
comprised of intense 1- to 3-min intervals with brief rest periods lasting 60 s. By
comparison, the methods of the selected studies that did not demonstrate the ergogenic
benefit of alkalosis were not sufficient in at least one aspect. Given that all of the
reviewed studies reported enhanced blood buffering capacity (when measured), this
insufficient methodology was likely due to poor timing of administration, placebo, or
exercise protocol intensity. For example, the protocol utilized by Tan et al. (2010)
resulted in a post-exercise pH of 7.32 units and a lactate concentration of only 5.8 mM in
the placebo trial. The authors reported that previous studies finding ergogenic efficacy for
NaHCO3 supplementation demonstrated post-exercise pH values of less than 7.2 units
and lactate concentrations in excess of 10 mM (Tan et al., 2010). This suggests that the
level of acidosis generated by this type of activity (water polo) is not sufficient enough to
warrant NaHCO3 administration. Another short-coming of the study may have been
timing of supplement administration. Ingestion was completed 90 min prior to an
exercise protocol that involved 40 min of exercise (not including rest periods). Based on
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the work by Siegler and others (2009), this suggests that the exercise protocol took place
during a time of tapering extracellular buffer capacity (Tan et al., 2010). Similar to the
results produced by Tan et al. (2010), Price and Simmons (2010) found induced-alkalosis
not to be ergogenic, suggesting that the exercise intensity utilized may not have been
sufficient to elicit excessive H+ production. Inadequate timing and insufficient exercise
intensity may also have been the confounding factors that prevented Materko et al. (2008)
from establishing ergogenic effects. In this study, ingestion was completed 120 min prior
to exercise testing, which involved only one bout of resistance exercise (Materko et al.,
2008). Since PCr depletion is likely the limiting factor in one bout of resistance exercise
(Lambert & Flynn, 2002), it seems unlikely this type of strength test would benefit from
NaHCO3 administration. Aschenbach et al. (2000) utilized a protocol with exercise
interval durations of only 15 s. The authors postulated that PCr depletion may be the
limiting factor in this type of exercise, even though the large lactate levels produced
suggest extensive fast glycolysis. However, other studies with intervals of even shorter
durations (Bishop et al., 2004; Lavender & Bird, 1989) established ergogenic effects, so
it remains unclear as to why Aschenbach et al. (2000) did not obtain significant results.
One possibility, though, is the fact that Aschenbach et al. (2000) used trained
participants. Although trained participants are likely to give more consistent
performances and therefore incorporate smaller variability (Matson & Tran, 1993),
training enhances buffering capacity (Edge et al., 2006), possibly reducing the
effectiveness of supplemental buffering. This may also have been a contributing factor in
the results found by Cameron et al. (2010). The authors used elite rugby players and
found no performance enhancement with supplemental NaHCO3. Timing of
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administration may have been a confounding factor as well, with participants consuming
the supplement approximately 100 min prior to exercise performance testing (Cameron et
al., 2010).
Methodological considerations of those studies that only demonstrated a trend
toward enhanced performance may elucidate why the results of those studies only
approached significance. Two potential complications of the Parry-Billings and
MacLaren (1986) study were the timing of supplement administration and rest period
lengths. Exercise testing did not begin until 150 min post ingestion, which is the same
time frame in which Renfree (2007) found that blood buffering capacity was no longer
significantly elevated. While this certainly could have influenced the results, the length of
time between sprints, six minutes, could have had an impact as well. This length of time
would have been sufficient to allow complete resynthesis of PCr (Cramer, 2008), thereby
diminishing the energy contributions, and subsequent H+ production, of fast glycolysis.
Similar to Parry-Billings and MacLaren (1986), Gaitanos et al. (1991) also incorportated
a 150-min period between ingestion and exercise, likely resulting in testing that occurred
well after peak blood buffering capacity. Another study with similar methodology to
Parry-Billings and MacLaren (1986) was that conducted by Matsuura et al. (2007). The
commonality was in the utilization of 6-min rest periods. Again, allowing this much time
between sprints likely allowed complete PCr repletion, reducing the contributions of fast
glycolysis. Along these lines, it is important to note that PCr hydrolysis actually
consumes H+ (Robergs et al., 2004); so any method that potentiates the contribution of
PCr to energy production actually reduces, if only briefly, intracellular H+ concentration.
The 60-s rest periods utilized by Kozak-Collins et al. (1994) are more in accordance with
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those studies (Costill et al., 1984; Lavender & Bird, 1989; McKenzie et al., 1986; Siegler
& Hirscher, 2010) employing exercise protocols generating significant acidosis.
Therefore, other methodological complications, primarily in the supplementation
protocol, may be responsible for a lack of significant results. Kozak-Collins et al. (1994)
did not begin exercise testing until 120 min post-ingestion. As previously discussed, this
may have led to exercise testing after peak blood buffering capacity occurred. In addition,
the authors administered a large dose of NaCl (0.207 g·kg-1) as a placebo (Kozak-Collins
et al., 1994). If NaCl is not physiologically inert, as some research suggests (Bishop et
al., 2004; Lavender & Bird, 1989), then the differences between group performances
could have been reduced, thereby yielding insignificant results.
Only two of the selected studies investigated the effects of induced-alkalosis on
high-volume resistance exercise (Portington et al., 1998; Webster et al., 1993). In the
study by Webster et al. (1993), four of the six participants increased number of
repetitions completed in the performance test, but the results were not significant. This
led the authors to suggest that NaHCO3 administration during a more intense protocol
may demonstrate ergogenic effects. To examine this hypothesis, Portington et al. (1998)
conducted a similar study with a greater intensity. Whereas Webster et al. (1993) utilized
a resistance load of 70% 1-RM, Portington et al. (1998) used a resistance corresponding
to approximately 12-RM for each set. This means that all sets were terminated at
momentary muscular failure, when participants were unable to complete another
repetition. Similar to the earlier study, seven of the 15 participants increased total number
of repetitions under induced-alkalosis, but the results were not significant (Portington et
al., 1998). Even though the protocols of these two studies are considered “high-volume,”
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this volume of exercise is still substantially less than that seen with typical HRE. For
example, Portington et al. (1998) reported that, on average, participants completed
approximately 60 total repetitions throughout the protocol. However, individuals training
for muscular hypertrophy may complete 15 to 20 exercise sets per muscle group
(Lambert & Flynn, 2002). Fifteen exercise sets with a 10-RM load equates to 150 total
repetitions, representing a 150% increase in the volume used by Portington et al. (1998).
It therefore follows that the ergogenic potential of NaHCO3 is more likely to be
maximized with an exercise protocol employing the type volume used in typical HRE
regimens.
Exercise protocols and performance summary. The effects of NaHCO3
administration have been examined on a variety of HIE modalities, among those being
cycling, running, swimming, sport-specific exercise tests, and resistance exercise. With
sound methodology, induced-alkalosis has the potential to enhance performance in all of
these modalities. Twenty-three of the reviewed studies found either significant increases
in performance or a trend toward enhanced performance following NaHCO3
supplementation. Those studies not demonstrating significant results may have utilized
insufficient methodology, such as inadequate exercise intensity or improper timing of
supplement administration. While no studies evaluated the effects of induced-alkalosis on
a true HRE protocol, previous research suggests that exercise of this volume and intensity
may be enhanced through NaHCO3 supplementation.
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CHAPTER III
MANUSCRIPT
The Effects of Sodium Bicarbonate Supplementation on Lower-Body Hypertrophy-Type
Resistance Exercise
Introduction
Specific muscular adaptations obtained through resistance exercise are dependent
upon training program design, with programs targeting muscle hypertrophy being
distinctive from those targeting muscular strength or endurance (Baechle et al., 2008;
Brooks et al., 2000). The American College of Sports Medicine (ACSM) has identified
several important program design variables, chief among those being exercise load, rest
periods, and exercise volume. Manipulation of these variables is associated with the
specific muscular adaptations, with hypertrophy-type resistance exercise (HRE) regimens
being characterized by moderate loads, short rest periods, and high total volume (ACSM,
2009). Typically, HRE regimens consist of 8-12-repetition maximums (RM) per exercise
set (Fleck & Kraemer, 1988; Linnamo et al., 2005; Spiering et al., 2008), rest periods of
approximately one minute between sets (Bird et al., 2005; de Salles et al., 2009; Kraemer
et al., 1987), and multiple sets of each exercise—with greater total exercise volumes
eliciting greater anabolic hormone concentrations (Gotshalk et al., 1997; Smilios,
Piliandis, Karamouzis, & Tokmakidis, 2003).
The fatigue associated with HRE regimens is likely to be multi-faceted, as this
type of exercise is both intense and prolonged. During intense exercise, multiple energy
substrates are depleted with the concurrent accumulation of metabolites, making it
difficult to determine if energy depletion or end/waste-product accumulation is the
primary cause of fatigue. For example, during high-intensity exercise, phosphocreatine
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(PCr) and glycogen are depleted (Lambert & Flynn, 2002; Tesch, Colliander, & Kaiser,
1986), while H+ and adenosine diphosphate (ADP) accumulate (Miller et al., 1988).
Resistance exercise confounds the problem since the source of fatigue during the first set
of 10 repetitions to muscular failure is likely different from the primary source of fatigue
during the later exercise sets (Lambert & Flynn, 2002). Type II muscle fibers are heavily
recruited during HRE, especially as greater muscular force is needed to either maintain or
increase work output (Spiering et al., 2008). The extensive fast glycolysis associated with
progressive recruitment of type II fibers results in concomitant increases in intracellular
lactate concentration ([Lac-]) and H+ concentration ([H+]) (Cramer, 2008; Medbo &
Tabata, 1993). The increasingly acidic intra- and extracellular pH is often implicated as a
major contributor to skeletal muscle fatigue (Materko et al., 2008; Sahlin et al., 1998).
Proposed mechanisms of this fatigue suggest that excessive intracellular H+ can reduce
both actomyosin ATPase activity and the affinity of troponin for calcium (Ca2+), thereby
reducing actin-myosin coupling and muscular force generating capacity (Allen et al.,
1995; Chin & Allen, 1998; Spriet et al., 1985). Excessive H+ may also interfere with Ca2+
release and sequestering by the sarcoplasmic reticulum (Fitts, 1994), reduce sarcolemma
excitability by enhancing the efflux of potassium (K+) from the cell (Broch-Lips et al.,
2007), and interfere with creatine kinase equilibrium (Sahlin et al., 1998) and
phosphofructokinase activity (Sutton et al., 1981; Trivedi & Danforth, 1966).
The presence of a buffer in a system allows for more acid, or H+, to be added to
that system before affecting a change in pH (Juel, 2008). While several buffer systems
attenuate elevations in [H+] within the human body, the chemical buffers serve as the first
line of defense against acidosis, reacting within a fraction of a second to correct acid-base
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disturbances (Guyton & Hall, 1996). The chemical buffers are comprised of proteins
(e.g., hemoglobin and albumin), small peptides (e.g., carnosine), dibasic Pi, and
bicarbonate (Juel, 2008; Sahlin et al., 1978). The bicarbonate system is regarded as the
most important extracellular buffering system for maintaining acid-base balance (Guyton
& Hall, 1996) and has been shown to buffer approximately 62% of the H+ released into
the blood during exhaustive exercise (Medbo et al., 2009). In an effort to enhance the
extracellular buffer system of athletes performing high-intensity exercise, investigators
have administered various alkalizing agents, with the most common being sodium
bicarbonate (NaHCO3) (McNaughton et al., 2008).
NaHCO3 supplementation to induce alkalosis and enhance exercise performance
has been in practice for decades (Webster, 2002). Since the bicarbonate ion (HCO3-) does
not readily permeate the sarcolemma (Mainwood & Cechetto, 1980), the hypothesis for
the efficacy of such supplementation is that an increase in the extracellular buffering
capacity facilitates the efflux of H+ from the intracellular compartment (Matson & Tran,
1993). This, in turn, attenuates the increase in [H+] and consequent fatigue that results
during high-intensity exercise (McNaughton et al., 2008). While the results of numerous
NaHCO3 studies are inconsistent, Webster (1993) identified several factors associated
with consistent performance enhancement. Specifically, ergogenic effects of inducedalkalosis are strongly associated with continuous exercise protocols resulting in
exhaustion in one to seven minutes, and those protocols utilizing high-intensity
intermittent exercise (HIE) (Webster et al., 1993). HIE studies have demonstrated
ergogenic effects during cycling (Costill et al., 1984; McKenzie et al., 1986) and
swimming (Gao et al., 1988; Zajac et al., 2009), as well as various sport-specific tasks
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(Artioli et al., 2007; Siegler & Hirscher, 2010; Wu et al., 2010). Although several HIE
studies have investigated the effects of NaHCO3 supplementation on resistance exercise
performance (Coombes & McNaughton, 1993; Maughan, Leiper, & Litchfield, 1986;
Verbitsky, Mizrahi, Levin, & Isakov, 1997), only two reported studies have investigated
the effects of induced-alkalosis on high-volume resistance exercise (Portington et al.,
1998; Webster et al., 1993).
Webster et al. (1993) first examined the effects of induced-alkalosis on highvolume resistance exercise utilizing a protocol consisting of four sets of 12 repetitions of
the leg press exercise at 70% 1-RM, with 90-s of recovery between sets. A fifth set to
muscular failure with the same load was employed as a performance test. Although four
of the six participants increased number of performance test repetitions, the results were
not statistically significant. The relatively minor acid-base perturbation associated with
the exercise protocol led the authors to suggest that a more intense protocol may be
necessary to elicit an ergogenic effect (Webster et al., 1993). Portington et al. (1998) took
this suggestion and conducted a similar study employing a greater exercise intensity.
Similar to the findings of Webster et al. (1993), seven of the 15 participants increased
total number of repetitions after induced-alkalosis; however, the results were again not
statistically significant (Portington et al., 1998). Of important note, neither protocol was
associated with the severe acid-base disturbances observed in previous studies utilizing
HIE protocols. Even though the protocols of these resistance exercise studies are
considered “high-volume”, the utilized volume was still substantially less than that seen
with typical HRE. For example, Portington et al. (1998) reported that participants
completed approximately 60 total repetitions throughout the exercise protocol. However,
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individuals training for muscular hypertrophy often complete 15 to 20 exercise sets per
muscle group (Lambert & Flynn, 2002). Fifteen exercise sets with a 10-RM load equates
to 150 total repetitions, representing a 150% increase in the volume used by Portington et
al. (1998). The greater exercise volume associated with HRE may be more likely to
create acid-base disturbances similar to that of other HIE modalities. If this is the case,
then HRE performance may potentially benefit from induced-alkalosis. Therefore, the
purpose of this study was to examine the effects of NaHCO3 administration during a
high-volume resistance exercise regimen for the lower body. Furthermore, the exercise
protocol was designed to mimic real-world hypertropy training, in an effort to elicit
greater metabolic demands than the protocols of Webster et al. (1993) and Portington et
al. (1998).
Methods
Participants. Twelve apparently healthy male participants (mean ± SD; age =
20.3 ± 2 yr, mass = 88.3 ± 13.2 kg, height = 1.80 ± 0.07 m) volunteered to participate in
this study and provided written informed consent. All participants had been involved in a
resistance training program utilizing lower body lifts for a minimum of two years. Each
participant was asked to refrain from his normal lower-body resistance training program
over the course of the study. Participants were instructed to avoid vigorous exercise 24
hours prior to all preliminary and experimental exercise testing sessions and to refrain
from eating for at least three hours prior to each session. This study was approved by The
University of Southern Mississippi Institutional Review Board for the use of human
participants in research.
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Each participant reported to the laboratory on approximately five different
occasions. Table 2 outlines the study design and procedures.
Table 2
Study Design and Procedures
Visit

Procedures

1

Informed consent, health history screening, height, weight, and blood pressure
assessment, familiarization of testing protocol and RM testing

2a

Exercise protocol familiarization and determination of baseline performance

2b

Replication of exercise protocol familiarization with performance within ± 10%
of visit 2a. If replicated performance variation was greater than ± 10%, an
additional replication session was performed before progressing to visit 3

3

Experimental testing: baseline resting blood sample #1 obtained,
supplementation with NaHCO3 or Placebo, blood sample #2 obtained 50min after complete ingestion of the supplement, standardized warm-up,
squats, leg presses, knee extensions, blood sample #3 obtained upon
completion of the exercise protocol, knee extension performance test,
blood sample #4 obtained immediately upon completion of the
performance test

4

Experimental testing: Repeat protocol from visit-3 with ingestion of alternate
supplement

Briefly, on the first visit to the laboratory, each participant engaged in a standardized
warm-up in preparation for a battery of lifting tests to estimate their repetition 1-RM
values for various lower-body exercises. The standardized warm-up consisted of pedaling
on a cycle ergometer (Monark 828E, Monark Exercise AB) for five minutes at a pedal
cadence of 65 revolutions per minute against a resistance of 1.0 kg. After cycling, each
participant performed one set of barbell back squats with a weight that easily allowed
completion of approximately 10 repetitions. After a 120-s rest period, participants
performed a battery of tests to determine a 3- to 5-RM value for the following exercises:
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back squat, inclined leg press, and knee extension. The lifting techniques are detailed
below. Rest periods of 3-5 min were utilized between RM lifts to allow for adequate
recovery between attempts (de Salles et al., 2009). From these 3- to 5-RM values, an
estimated 1-RM value (i.e., the maximal amount of weight that could be lifted one time)
was calculated utilizing the Epley formula, as follows: 1-RM = (1 + 0.0333 · repetitions) ·
repetition weight (Epley, 1985). This formula provides a valid estimate of the
participant’s 1-RM for lower body lifts while minimizing the risk of injury from
excessively heavy loads (Naclerio, Jimenez, Alvar, & Peterson, 2009). This estimated 1RM value was subsequently used to assign exercise resistance during the exercise
protocol.
Exercise protocol familiarization and determination of baseline performance
data. The selected exercise protocol was based on a similar, albeit slightly more
intensive, resistance exercise protocol demonstrated to have a significant impact on
muscle glycogen metabolism (Tesch, Colliander, & Kaiser, 1986). The protocol was also
based on the exercise order principle, with multi-joint, large musculature exercises being
performed first and single-joint exercises being performed last (Baechle et al., 2008).
Following the standardized warm-up detailed above, the exercises progressed from back
squats, to inclined leg presses, to knee extensions. Rest intervals throughout the exercise
protocol ranged from 60 to 120 s, falling within the recommended guidelines for
maximizing muscular hypertrophy (ACSM, 2009). Each exercise was conducted in
accordance with the National Strength and Conditioning Association (NSCA) guidelines,
and all participants were instructed on proper form for all exercises by a Certified
Strength and Conditioning Specialist. Before progressing to the experimental exercise

60
sessions, the exercise protocol was replicated during familiarization sessions on separate
days, with the performance (as determined by exercise volume) varying by no more than
± 10%. Once performance was adequately replicated, participants were progressed to the
two identical experimental testing sessions, one with administration of the Placebo and
one with the administration of the Treatment (NaHCO3).
Back squat—Following the standardized warm-up (as detailed above), each
participant began the protocol with barbell back squats. Each participant performed four
sets of back squats, using a load that allowed approximately 10- to12-RM per set. The
weight was adjusted to allow the necessary repetitions in each set. The approximate
intensities were as follows: set 1: 75% 1-RM, set 2: 70% 1-RM, set 3: 70% 1-RM, set 4:
65% 1-RM. The participants rested 90 s between squat sets. Each squat repetition was
completed in a controlled manner. Each participant lowered the weight until his knees
were at approximately 90° of flexion and his thighs parallel with the ground.
Inclined leg press—Following a 120-s recovery period after completion of the last
back squat set, each participant commenced with the inclined leg press exercise. The
participants performed four sets of inclined leg presses, again using a load that allowed
approximately 10- to 12-RM per set. As with the squats, the weight was adjusted to allow
the necessary repetitions in each set. Each participant rested 90 s between leg press sets.
Each leg press repetition was completed in a controlled manner, with the weight lifted
until the knees approached full extension, the weight lowered until the knees were at
approximately 90° of flexion, and the buttocks remaining in contact with the seat.
Knee extension—Following another 120-s rest period after completion of the last
inclined leg press set, each participant commenced with the knee extension exercise. The
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participants performed four sets of bilateral knee extensions, again using a load that
allowed approximately 10- to 12-RM per set. As with the previous exercises, the weight
was adjusted to allow the necessary repetitions in each set. The participants rested 60 s
between knee extension sets, with the shorter rest interval reflecting the relatively smaller
musculature involved with the exercise (de Salles et al., 2009). Each knee extension
repetition was completed in a controlled manner similar to that outlined previously. A
leather harness, fixated around each participant’s waist and the back pad of the machine,
was utilized to keep the participant from raising the buttocks off the seat.
Knee extension performance test—Three minutes after completion of the fourth
set of knee extensions, participants completed another set of knee extensions utilizing the
same form; however, this time the load was set at approximately 50% 1-RM, and the
participant completed as many repetitions as possible to a point of momentary muscular
failure.
Experimental testing sessions and supplementation. Each participant performed
two experimental trials in a randomized, double-blind, counterbalanced fashion. The
Treatment trial required the participant to consume 0.3 g·kg-1 NaHCO3, while the Placebo
trial required the participant to consume 0.3 g·kg-1 calcium carbonate (CaCO3). These
exogenous agents and dosages are consistent with those utilized in previous studies
(Artioli et al., 2007; Renfree, 2007; Siegler & Hirscher, 2010; Siegler et al., 2009). Both
the NaHCO3 and Placebo were administered in gelatin capsules (size 00). With ingestion
of the capsules, the participants consumed a total of approximately1.6 l of fluid. The
supplement was divided into four equal doses, with each dose consumed at 10-min
intervals (Matsuura et al., 2007). The first two doses were each consumed with
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approximately300-ml of a low-sodium, carbohydrate-electrolyte beverage (Gatorade, The
Gatorade Co.). Also, to minimize potential for GI distress, participants consumed a plain
bagel during the time allotted for consumption of the first two doses. The second two
doses were consumed with equal volumes of water (i.e., 500 ml per dose). Dose one was
consumed 80 min prior to the warm-up, with doses two, three, and four being consumed
at 70, 60, and 50 min prior to warm-up, respectively. Supplementation was administered
in this incremental fashion and over a 30-min period in an effort to minimize the potential
for GI distress, while at the same time peaking blood buffering capacity to coincide with
the onset of the exercise protocol (Siegler et al., 2009).
Blood sampling and analysis. Arterialized capillary blood was collected four
times during each experimental protocol. To create a hyperemic fingertip, a topical
vasodilator ointment (Finalgon, Boehringer Ingelheim) was applied to the distal aspects
of the third and fourth fingers of the left hand. Ten minutes after the application of the
ointment, the hand and distal forearm were soaked for 10 min in a hot water bath
maintained at 43-45°C. Immediately upon removal and drying of the hand, the fingertip
was sterilized with an alcohol wipe and punctured with a one-use safety lancet (21-gauge
blade; 1.8 mm depth; Prevent, Select Medical Systems). After discarding the initial drop
of blood, a balanced-heparin capillary tube (115 µL; Safe-T-Fill, Ram Scientific, Inc.)
was utilized to collect a free-flowing sample within approximately 15 s. The preceding
protocol was based on a similar blood sampling procedure that has been utilized to obtain
fingertip specimens that accurately reflect arterial samples (Zavorsky, Lands, Schneider,
& Carli, 2005). Once the sample was collected and mixed within the capillary tube, 95 µl
was transferred into a blood gas analysis cartridge (CG4+, Abbott Laboratories) and
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assessed by a portable clinical analyzer (i-STAT, Abbott Laboratories). The CG4+
cartridge analytical panel includes the following variables: pH, bicarbonate concentration
([HCO3-]), partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2),
total carbon dioxide (TCO2), saturated oxygen (SO2), base excess (BE), and lactate
concentration ([Lac-]). The i-STAT analyzer, which was systematically calibrated with
both a simulator (i-STAT Electronic Simulator, Abbott Laboratories) and known control
solution (i-STAT Control Level 3, Abbott Laboratories), has been shown to produce
reliable measures of the above blood gases and analytes across various exercise
intensities (Dascombe, Reaburn, Sirotic, & Coutts, 2007).
The above procedures were replicated for the first two blood samples. The first
sample (baseline) was collected immediately prior to supplementation. The second
sample was collected 50 min after ingestion of supplement dose four, just prior to the
warm-up exercise. Just prior to the incline leg press exercise, the vasodilating ointment
was reapplied to the third and fourth fingertips of the left hand, allowing the ointment an
activation period of approximately 10 min before the hand was re-submerged in the water
bath in preparation for the third blood sample. The third sample was collected
immediately after the completion of the knee extension exercise, prior to the performance
test. During the knee extension exercise, the hot water bath was placed adjacent to the
knee extension machine. To facilitate blood flow, the participant’s left hand/forearm was
placed into the bath for the duration of the knee extension exercise. Upon completion of
the fourth set, the participant’s hand was withdrawn from the water, and the third blood
sample was collected. Immediately following collection of the third sample, the
participant’s hand/forearm was returned to the hot water bath and remained there
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throughout the performance test. Upon completion of the performance test, the
participant’s hand was removed from the bath, and the fourth blood sample was
collected.
Statistical analyses. All values are reported as mean ± SD. All analyses were
conducted with a statistical software package (SPSS v. 19, SPSS, Inc.). The data were
analyzed with parametric statistics following confirmation of normal distribution by
Shapiro-Wilk tests. Repeated-measures ANOVA was utilized to assess the effects of time
(blood samples one, two, three, and four) and treatment (NaHCO3 and Placebo) on pH,
[HCO3-], BE, and [Lac-]. Greenhouse-Geisser corrections were utilized when the
assumption of sphericity was violated. When significant main effects (time, treatment)
and interactions (time x treatment) were found, post hoc analyses (pair-wise comparisons
utilizing dependent samples t-tests) were employed to identify where significant
differences existed within each variable of interest. All exercise performance data were
analyzed with paired t-tests. The exercise performance variables of interest were total
squat (SQ) repetitions, total incline leg press repetitions (LP), total knee extension (KE)
repetitions, total exercise protocol volume (SQ + LP + KE), performance test (PT)
repetitions, and overall total volume (SQ + LP + KE + PT). Also, to track the effects of
accumulation of exercise volume, total repetitions for the squat and leg press exercises
(SQ + LP), as well as for the leg press and knee extension exercises (LP + KE), were
analyzed. Statistical significance was accepted at P < 0.05.
Results
Blood acid-base parameters. Values for the blood acid-base parameters of interest
are presented in Table 3.
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Table 3
Blood Acid-Base Parameters
Blood Sample
Parameter

(1) baseline

(2) 50-min POST

(3) POST EX

(4) POST PT

7.49 ± 0.02a,b
7.42 ± 0.02

7.35 ± 0.04a,b
7.28 ± 0.04a

7.35 ± 0.04a,b
7.30 ± 0.03a,c

31.50 ± 2.59a,b
25.38 ± 1.78

16.80 ± 3.60a,b
13.81 ± 3.00a

17.86 ± 3.63a,b,c
14.79 ± 2.62a,c

7.92 ± 2.57a,b
1.08 ± 2.11

-8.75 ± 4.27a,b
-12.83 ± 3.38a

-7.67 ± 4.16a,b,c
-11.50 ± 3.29a.c

1.83 ± 0.33a
1.68 ± 0.46a

17.92 ± 2.08a,b
15.55 ± 2.50a

17.16 ± 2.09a,b,c
14.92 ± 2.45a,c

pH
NaHCO3 7.43 ± 0.02 b
Placebo 7.42 ± 0.02
[HCO3-]

(mEq·l-1)

NaHCO3 26.23 ± 2.11
Placebo 25.72 ± 2.25
BE

(mEq·l-1)

NaHCO3 1.92 ± 2.11
Placebo 1.33 ± 2.23
[Lac-]

(mEq·l-1)

NaHCO3 1.00 ± 0.33
Placebo 1.16 ± 0.37
a—significantly different than baseline
b—significantly different than Placebo

c—significantly different than POST EX

significance accepted at P < 0.05
values expressed as mean ± SD

There were no significant differences in the resting (baseline) values for [HCO3-] (P =
0.35), BE (P = 0.34), or [Lac-] (P = 0.18) between the NaHCO3 and Placebo conditions;
baseline pH was higher for the NaHCO3 condition (P < 0.05). At 50-min post-ingestion
of supplement dose 4 (50-min POST), NaHCO3 administration significantly elevated pH
(P < 0.05), [HCO3-] (P < 0.05), BE (P < 0.05), and [Lac-] (P < 0.05) above baseline
values. Placebo administration had no effect on pH (P = 0.18), [HCO3-] (P = 0.37), or BE
(P = 0.49) at 50-min POST; however, [Lac-] was significantly elevated (P < 0.05).
Immediately after the exercise protocol (POST EX), pH, [HCO3-], and BE were
significantly lower than baseline values for both groups (P < 0.05 for all parameters);
however, the NaHCO3 group values for all POST EX parameters were significantly
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higher than the placebo POST EX values (P < 0.05 for all parameters). [Lac-] was
significantly elevated over baseline for both groups POST EX (P < 0.05), with the
NaHCO3 group demonstrating significantly higher [Lac-] than the placebo group (P <
0.05). The blood acid-base parameters assessed immediately after the performance test
(POST PT) followed the same trend as the POST EX data, with all values of pH,
[HCO3-], and BE being significantly lower than baseline (P < 0.05), and [Lac-] being
significantly higher than baseline (P < 0.05). The same trend as the POST EX data was
also evident when comparing group POST PT data, with all parameter values being
significantly different (P < 0.05) between the NaHCO3 and Placebo conditions. The
within-group acid-base parameters for blood samples three (POST EX) and four (POST
PT) significantly differed in terms of Placebo pH (P < 0.05), NaHCO3 and Placebo
[HCO3-] (P < 0.05 for both conditions), NaHCO3 and Placebo BE (P < 0.05 for both
conditions), and NaHCO3 and Placebo [Lac-] (P < 0.05 for both conditions).
Side-effects of supplementation. Supplementation was well tolerated by the
majority of the participants during the experimental testing procedures. Only one
participant reported negative side-effects (light-headedness and belching) during the
exercise protocol following NaHCO3 administration. Two participants in the NaHCO3
condition reported being nauseated after completion of all experimental testing
procedures. One participant in the Placebo condition reported nausea acutely after
cessation of the exercise protocol.
Exercise performance. Resistance exercise repetitions completed during the
experimental testing procedures are presented Table 4.
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Table 4
Resistance Exercise Repetitions
Supplementation
Exercise(s)

NaHCO3

Placebo

Percent Difference
Between Conditions (%)

SQ (total repetitions)

43.4 ± 5.6

41.8 ± 4.8

3.8

LP

49.3 ± 8.9

46.3 ± 7.9

6.5

92.7 ± 10.0 a

88.1 ± 10.5

5.2

KE

47.2 ± 5.8

46.3 ± 6.7

1.9

LP + KE

96.4 ± 11.4

92.7 ± 11.2

4.0

139.8 ± 13.2 a

134.4 ± 13.5

4.0

23.8 ± 4.0

22.3 ± 3.7

6.7

163.7 ± 15.1 a

156.7 ± 14.5

4.5

SQ + LP

SQ + LP + KE
PT
SQ + LP + KE + PT

individual exercises presented in order of exercise protocol:
SQ—back squats  LP—inclined leg presses  KE—knee extensions
plus (+) represents accumulation of repetitions over specified exercises

a—significantly greater than Placebo
significance accepted at P < 0.05
values expressed as mean ± SD, unless specified

Although participants generated more total repetitions per individual exercise (SQ, LP,
and KE) following NaHCO3 administration, there were no significant differences
between groups for total repetitions for SQ (P = 0.18), LP (P = 0.06), or KE (P = 0.34).
However, significant differences became apparent as exercise volume accumulated. For
example, the NaHCO3 group generated more repetitions than the Placebo group during
the SQ (43.4 ± 5.6 vs. 41.8 ± 4.8) and LP (49.3 ± 8.9 vs. 46.3 ± 7.9) exercises
individually, but these differences were not significant. The accumulated repetitions over
these two exercises (SQ + LP), however, was significantly different between groups
(NaHCO3 = 92.7 ± 10.0, Placebo = 88.1 ± 10.5, P < 0.05). Along these lines, NaHCO3
administration also resulted in significantly more total repetitions generated over the
exercise protocol (SQ + LP + KE; NaHCO3 = 139.8 ± 13.2, Placebo = 134.4 ± 13.5, P <
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0.05). Performance test (PT) repetitions were not significantly different between groups
(NaHCO3 = 23.8 ± 4.0, Placebo = 22.3 ± 3.7, P = 0.11). However, overall total volume
(SQ + LP + KE + PT) was significantly greater following NaHCO3 administration (163.7
± 15.1 vs. 156.7 ± 14.5, P < 0.05).
Discussion
In the first study examining the effects of NaHCO3 administration on highvolume resistance exercise, Webster et al. (1993) found that, while four of the six
participants in the Treatment condition increased repetitions during the performance test,
there was no significant difference between the NaHCO3 and Placebo groups. Portington
et al. (1998) followed up this earlier study with a similar, albeit more intensive, protocol
to assess the Webster et al. (1993) hypothesis that a more intensive resistance training
regimen may elicit ergogenic effects. Despite the greater exercise intensity (LP: 5 sets x
~12-RM vs. 4 sets x 12 reps/set at 70% 1-RM, with 5th set to failure), Portington et al.
(1998) failed to demonstrate ergogenic efficacy for supplementation. The main purpose
of the present study was to examine the effects of NaHCO3 administration on an even
more intensive, lower-body resistance exercise protocol, one that more closely mimics a
regimen designed to elicit hypertrophy. The primary findings of the present study were
that, in contrast to the previous high-volume resistance exercise studies, supplementing
with 0.3 g·kg-1 NaHCO3 was an effective means of significantly improving HRE
performance, allowing for the completion of more accumulated repetitions throughout the
protocol. Table 5 provides a comparison of the present study to the previous two highvolume studies.
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Table 5
Comparison of Acid-Base Parameters and Accumulated Repetitions
Among the High-Volume Resistance Exercise Studies
POST EX Blood Acid-Base Parameters
Repetitions
(exercise)

pH
(units)

HCO3(mEq·l-1)

BE
(mEq·l-1)

Lac(mEq·l-1)

LP = 48
PT = 18.2
Total = 66.2

7.25

15.4

-10.7

9.8

Portington
et al. (1998)

LP = 60
Total = 60

~7.25

14.0

-12.3

11.3

Present

SQ = 41.8
LP = 46.3
LE = 46.3
Total = 134.4

7.28

13.8

-12.8

15.6

Study
Webster et
al. (1993)

values presented are from Placebo trials
values expressed as means

POST EX—immediately after exercise protocol

The present study utilized an exercise regimen that was more prolonged and intense than
the previous high-volume resistance exercise studies, as evidenced by the fact that the
protocol of this study elicited substantially greater [Lac-] and resulted in larger declines in
[HCO3-] and BE (see Table 5). The larger acid-base disturbance is suggestive of a greater
intracellular to extracellular pH gradient and could explain, at least in part, why NaHCO3
administration resulted in significant performance improvement in this more prolonged
protocol. The present study, however, was similar to Portington et al. (1998) in that
NaHCO3 supplementation failed to elicit ergogenic effects following one multi-set
exercise involving approximately10- to 12-RM loads. Total repetitions in the present
study, although higher for the NaHCO3 group, were not significantly different between

70
groups following the first exercise (SQ). However, following the second exercise (LP),
the accumulated repetitions (SQ + LP) by the NaHCO3 group were significantly greater
than the Placebo group (92.7 ± 10.0 vs. 88.1 ± 10.5) and represented a 5.2% increase
from Placebo to NaHCO3 trial. This trend was maintained after the KE exercise, with the
total resistance exercise volume being significantly higher for the NaHCO3 group (see
Table 4). Enhanced performance occurring only during the later bouts of exercise is a
common trend seen with HIE studies (Artioli et al., 2007; Bishop et al., 2004; Gao et al.,
1988; Wahl et al., 2010). Improved performance following a single bout of high-intensity
exercise is typically not seen under the condition of induced-alkalosis, likely because the
acid-base disturbances associated with the exercise are not sufficient to establish a strong
enough pH gradient to substantially facilitate H+ efflux from the cell to the interstitium
(Matson & Tran, 1993). This seems to suggest that, had Webster et al. (1993) or
Portington et al. (1998) utilized a more prolonged exercise protocol, ergogenic efficacy of
NaHCO3 supplementation may have been demonstrated, as was the case for the present
study.
Although the NaHCO3 group performed more PT repetitions (Placebo: 22.3 ± 3.7;
NaHCO3: 23.8 ± 4.0, representing a 6.7% increase over Placebo trial), there was not a
significant difference between group means. This is not surprising since, prior to the PT,
the NaHCO3 group performed significantly more total repetitions throughout the exercise
protocol (see Table 4). While PT repetitions were not statistically different, overall total
repetitions (SQ + LP + KE + PT) were a significant 4.5% higher for the NaHCO3 trial.
This greater volume of work performed during the NaHCO3 trial corresponded to
significantly higher [Lac-] (17.16 ± 2.09 vs. 14.92 ± 2.45, POST PT), suggesting that
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greater metabolic demands were associated with the greater work output following
NaHCO3 administration. Along these lines, several mechanisms accounting for the
observed significant differences in [Lac-] accompanying exercise under induced-alkalosis
have been postulated. The greater alkaline state of the NaHCO3 group in the present
study could have stimulated intramuscular glycolytic flux by upregulating the activity of
the glycolysis/glycogenolysis regulatory enzymes phosphofructokinase and glycogen
phosphorylase (Hollidge-Horvat, Parolin, Wong, Jones, & Heigenhauser, 2000; Trivedi
& Danforth, 1966). An elevation in intracellular [Lac-] could potentially facilitate Lacflux from the muscle cell, ultimately increasing blood [Lac-]. However, Hollidge-Horvat
et al. (2000) demonstrated that an elevated intracellular [Lac-] likely did not drive Lacefflux, leading the authors to suggest that upregulation of the monocarboxylate lactate
transporters (Lac-/H+ co-transporters) was potentially responsible for the significantly
elevated blood [Lac-] following induced-alkalosis. While some research echoes this
sentiment (Messonnier, Kristensen, Juel, & Denis, 2007), other studies have failed to
demonstrate enhanced Lac- efflux altogether, leading to the suggestion that the elevated
[Lac-] is possibly due to reduced Lac- uptake, or clearance from the blood by the body’s
tissues, rather than enhanced efflux (Raymer, Marsh, Kowalchuk, & Terry, 2004;
Stephens et al., 2002). While all of the aforementioned mechanisms are plausible, the
exact cause of elevated [Lac-] following NaHCO3 administration remains to be fully
elucidated.
Increases in muscle cross-sectional area represent the principle desired adaptation
to HRE training. From a practical standpoint, a nutritional supplement would need to
have the propensity to potentiate muscle growth to warrant its use in conjunction with
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HRE training. A major finding of the present study is that NaHCO3 administration can
improve resistance exercise performance, allowing for the completion of more total
repetitions over the course of a training session. This would seem to suggest that inducedalkalosis allows for greater training intensity, which could potentially result in greater
training adaptations (e.g., hypertrophy). However, the literature examining the effects of
induced-alkalosis on more prolonged training regimens is relatively limited. Edge et al.
(2006), when examining the effects of eight weeks of sprint training combined with
NaHCO3 administration, found that induced-alkalosis improved lactate threshold and
short-term endurance capacity, while resulting in similar improvements in muscle
buffering capacity as the Placebo group. The investigators concluded that training
intensity, and not H+ accumulation, was the principle determinant of training adaptations
(Edge et al., 2006). Given that the degree of muscular hypertrophy following a resistance
training program is partly dependent upon exercise intensity (Fry, 2004), it stands to
reason that induced-alkalosis may also elicit favorable training adaptations over the
course of a resistance training program. However, no studies investigating the effects of
induced-alkalosis on chronic resistance training have been reported.
Whether or not greater training intensity translates into greater training
adaptations depends, at least in part, on hormonal responses to the exercise. Previous
research has shown that HRE significantly elevates the concentrations of both growth
hormone ([GH]) and testosterone (Kraemer, Gilgore, Kraemer, & Castracane, 1992;
Linnamo et al., 2005), with only [GH] being significantly elevated after correcting for
plasma volume shifts (Kraemer, 1992). In studying the effects of induced-alkalosis on the
GH response accompanying 90 s of maximal cycling, Gordon et al. (1994) demonstrated
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that NaHCO3 administration resulted in significantly lower [GH] than placebo
administration. This led the authors to conclude that H+ may partly be responsible for GH
stimulation (Gordon et al., 1994). Wahl et al. (2010) conducted a similar study, this time
investigating the hormonal response to an HIE cycling protocol. The investigators found
that induced-alkalosis blunted both the GH and cortisol responses, leading to the
suggestion that acidosis plays a role in the growth and turnover of skeletal muscle. If this
is the case, then administration of NaHCO3 before HRE may not be advisable, since
alkalosis may decrease the stimulus for muscle growth.
Other studies, however, contradict the results of Wahl et al. (2010) and Gordon et
al. (1994), indicating that pH may not play a significant role in GH stimulation. Sutton et
al. (1976) administered NaHCO3, ammonium chloride (NH4Cl), or Placebo to examine
the effects of pH on GH response during cycling at different intensities. The investigators
found that, while all stages of the variable-intensity cycling protocol increased [GH],
there was no correlation between pH and GH. Similarly, Elias et al. (1997) found that an
incremental cycling protocol elevated GH, but there was not a significant difference
between the NaHCO3 and Placebo treatments. In accordance with the equivocal findings
of the affects of pH on GH, other mechanisms governing the GH response to exercise
have been suggested, among those being neural stimulation, nitric oxide production, and
catecholamine response (Godfrey, Madgwick, & Whyte, 2003). It should also be noted
that many of the effects of GH are attributed to the downstream mediation of insulin-like
growth factor I (IGF-I), with minimal contribution from sarcolemmal interaction of GH
and its receptor (Godfrey et al., 2003). This is important because research has shown that
induced-alkalosis does not affect the IGF-I response to exercise (Kraemer et al., 1992;
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Wahl et al., 2010), with some research even demonstrating an increase in [IGF-I]
following exercise under induced-alkalosis (Kraemer, Harman, Vos, Gordon, Nindl,
Marx et al., 2000). Also important to note is the fact that the blunted cortisol response
demonstrated by Wahl et al. (2010) may not be deleterious to training adaptations.
Tarpenning et al. (2001), utilizing carbohydrate supplementation to blunt the cortisol
response to resistance exercise, found that attenuation of cortisol levels resulted in
significant hypertrophy after a 12-week training program. This suggests that inducedalkalosis may actually enhance, rather than diminish, the muscular hypertrophy
accompanying HRE. Taken together, the above information warrants further
investigation into the effects of induced-alkalosis on the adaptations occurring during
prolonged HRE training.
In conclusion, NaHCO3 administration in the present study significantly improved
total accumulated repetitions during a lower-body HRE regimen. These results are in
contrast to the findings of previous studies examining the effects of induced-alkalosis on
high-volume resistance exercise. Webster et al. (1993) and Portington et al. (1998) were
unable to demonstrate significant ergogenic efficacy of NaHCO3 utilizing multiple sets of
a single lower-body exercise. Since exercise protocols designed to elicit muscular
hypertrophy typically contain substantially greater volume than that used by the previous
two “high-volume” studies, the present study sought to employ a more realistic HRE
regimen, with multiple exercises utilizing four sets of approximately10- to 12-RM loads
and short rest periods. The greater exercise volume associated with this HRE protocol
elicited significant metabolic demands, while inducing significant acid-base
perturbations. This appears to be the combination necessary to demonstrate the ergogenic
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efficacy of NaHCO3 administration. For supplementation of this nature to be practical for
real-world use in conjunction with HRE, the enhanced exercise performance must
translate into enhanced training adaptations. As there have been no reported
investigations into the effects of induced-alkalosis on chronic resistance training, future
studies should examine the impact of NaHCO3 administration on the training adaptations
associated with HRE.
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APPENDIX B
INFORMED CONSENT
UNIVERSITY OF SOUTHERN MISSISSIPPI
CONSENT TO ACT AS A HUMAN SUBJECT
Subject’s name:

Date:

Project title:
“The effects of sodium bicarbonate supplementation on a hypertrophy-type resistance exercise
regimen.”
Description and explanation of procedures:
You are invited to participate in a research study investigating sodium bicarbonate (i.e. baking
soda) and its effects on hypertrophy-type (muscle building) resistance exercise for the lower body. All
procedures will be conducted in Heidelburg Gymnasium at Belhaven University. The requirements for
participation as a subject are as follows:
1.
2.

Apparently healthy males between 18 and 35 years of age.
Regular participation in a resistance training program involving the lower body for a minimum of
the past 2 years.

Approximately 12-15 participants are being recruited for participation in this study and
representation from all racial and/or ethnic groups will be encouraged.
After reading this informed consent, this form will also be read to you by either the principle
investigator or a research assistant. At that time, any of your questions or concerns will be addressed by
either or both of these individuals. Once written informed consent is provided, you will complete a medical
history questionnaire and will be measured for height, weight, and blood pressure. If your systolic blood
pressure is greater than 140 or your diastolic blood pressure is greater than 90, you will be excluded from
the study. After these measures are obtained, you will be familiarized with the resistance exercise regimen
and assessed for 3-5 repetition maximum (RM) lifts on the back squat, inclined leg press, and knee
extension exercises. After a minimum of 72 hours, you will return to the gymnasium and engage in the full
exercise regimen. After a minimum of another 72 hours, you will return once again and complete an
identical protocol. This procedure will be repeated as many times as is necessary for your performance on
two successive exercise sessions to vary by no more than ± 5-10%. Once your performance is adequately
replicated, the study will proceed to the experimental trials. During the experimental trials, you will
complete identical exercise protocols after supplementation with either sodium bicarbonate (baking soda)
or a calcium carbonate placebo. The amount of supplement that you consume will equate to 0.3 grams per
kilogram of body weight. For a 70-kilogram (154-pound) person, this would result in the consumption of
21 grams of the supplement. The supplementation will be contained in gelatin capsules, each containing
approximately 1 gram of supplement. For the previous example (70-kilogram person), this would lead to
the consumption of 21 capsules.
Sodium bicarbonate supplementation has been shown to induce alkalosis within the blood and
enhance performance in high-intensity intermittent exercise. This performance enhancement likely occurs
through the attenuation of the metabolic acidosis that accompanies high intensity exercise. During high
intensity exercise such as resistance exercise, hydrogen ions accumulate in the active tissues/blood and
decrease the pH of the intra- and extracellular fluids. A reduction in pH is strongly associated with the
fatigue experienced during exercise. In order to assess pH and various other analytes, very small blood
samples will be collected 4 times throughout the experimental exercise trials through a minimally invasive
technique. A one-use safety lancet will be used to prick the fingertip, and a capillary tube will be utilized to
collect the sample.
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The following is an outline of the protocol:
Visit 1

Informed consent, health history screening, height, weight,
and blood pressure assessment. Familiarization of testing
protocol and repetition maximum testing.

Visit 2a
Visit 2b
Visit 2c

Perform the exercise protocol.
Perform the exercise protocol.
Perform the exercise protocol until performance with previous
trials is within ±5-10%.
Assuming exercise volume is adequately replicated…

Visit 3

Visit 4

*Baseline resting blood sample.
*Supplementation with either sodium bicarbonate or calcium
carbonate.
*Blood sample 90 minutes after supplementation.
*Standardized warm-up. Squats. Leg presses. Knee extensions.
*Blood sample upon completion of exercise regimen.
*Knee extension performance test.
*Blood sample upon completion of performance test.
Repeat protocol from previous visit with alternate
supplementation.

Visits will be separated by a minimum of 72 hours to allow for recovery from exercise.
Time commitment from the participant is approximately 30 minutes for each of Visits 1and 2a,b,c,
and 3 hours for each of Visits 3 and 4. Approximate total time required is 7.5 hours.
Risks and discomforts:
With any exercise there are potential health risks; however, measures will be taken to minimize
these risks. Some of the possible risks from participation in this study include:
1.
Abnormal heart responses to the exercise.
2.
Muscle soreness resulting from the exercise.
3.
Dizziness, nausea, vomiting, chest pain, heart attack, stroke or death due to
performing physical exercise.
4.
Pain associated with fingertip puncture.
5.
Ill effects due to supplementation. Although baking soda supplementation is
typically well tolerated, some commonly reported side effects of
supplementation include bloating, gas, burping, nausea, diarrhea, and lightheadedness.
Some of the measures taken to prevent or minimize the occurrence of health risks include:
1.
The researchers are trained in cardiopulmonary resuscitation (CPR) and First
Aid. The neighboring on-call athletic training staff is trained in emergency
management.
2.
At least one Certified Strength and Conditioning Specialist will always be on
hand to ensure proper lifting and spotting techniques.
3.
Large volumes of water will be consumed with the supplementation to reduce
the likelihood of gastrointestinal discomfort. Over 1.5 liters of fluid will be
consumed with supplementation in order to dilute the baking soda. Participants
will also be encouraged to continue to drink fluids throughout the exercise
regimen to maintain the dilution. The supplement will also be administered in
smaller doses taken over a period of time to further reduce the potential for
gastrointestinal distress.
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Neither the University of Southern Mississippi nor Belhaven University has a mechanism to
provide you compensation if you incur injuries as a result of participation in this research project.
However, efforts will be made to make available the facilities and professional skills of the research staff.
Mr. Ben Carr will either be present or on call at all times should a research-related injury or illness occur.
Should you experience such a problem, please call Ben Carr at (601) 421-2195 (cell) or (601) 968-8964
(office). In the event that you are unable to reach Ben Carr, you may also call Dr. Don Berryhill at (601)
974-6458 (office) or the Belhaven Athletic Training staff at (601) 968- 8789. In the event that it is
determined that you need the attention of a physician, you will be referred to either your personal
physician, the physician at the Belhaven clinic, or one of the local emergency rooms. Any of these
physicians will be available to you, but there will be a fee involved in use of their services. This is a
double-blind study, which means that neither the researcher nor you will know to which group you have
been assigned. Upon completion of the study, you will be informed as to which group you were assigned.
In the event of a medical emergency, or you request that this information be divulged, the code will be
broken prior to completion of the study. However, this will necessitate that you discontinue participation in
the study.
Potential benefits:
As a participant in this study, you will receive knowledge about your body’s
physiological responses to common resistance training exercises. You will also receive
information about your repetition maximums for common resistance exercises, as well as guidance
in techniques to achieve maximum muscular hypertrophy. The results of this study may provide
insight into a relatively inexpensive method of maximizing work output during a resistance
training regimen, thereby potentiating muscle growth. For your participation, you will be
compensated $50. You will receive $10 after completion of the first experimental testing session,
with the remaining $40 being provided upon completion of the last testing session.
Confidentiality:
All data will be dealt with using a numerical code to identify you, the participant. The
coding will only be known by the investigators. Individual participant information will only be
released upon written request to the principle investigator by the participant, or in the event of a
medical emergency, by the participant’s physician. All data will be on file in the office of the
principle investigator, and only the principle investigator or assistant will be allowed to examine
the data collected on the participant. Only group data will be disclosed upon completion and
publication of this investigation. Data will be kept on file in the office of the principle investigator
for three years, after which time all data will be destroyed.
Consent:
Information about the procedures described above and the possible risks and benefits of the project
have been explained. Whereas no assurance can be made concerning results that may be obtained, the
researcher will take every precaution consistent with the best scientific practice. Questions concerning the
research should be directed to Ben Carr (601) 968-8964 (office) or (601) 421-2195 (cell). This project and
this consent form have been reviewed by the Human Subjects Protection Review Committee, which
ensures that research projects involving human participants follow federal regulations. Any questions or
concerns about rights as a research subject should be directed to the Director of Research and Sponsored
Programs, University of Southern Mississippi, Box 5157, Hattiesburg, MS 39406,
(601)-266-4119.
Participation in this project is completely voluntary, and you are free to withdraw at any time
without penalty or prejudice, or loss of benefits. In addition, all personal information is strictly confidential
and no names will be disclosed. During the course of the study, your information will be identified by a
letter-number combination. Any new information that might develop during the course of the project will
be provided to you if that information might affect your willingness to participate in the project.
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Consent to participate in this project is hereby given by the undersigned. A copy of this form has
been given to me.

Date

Subject’s signature

Date

Signature of Researcher explaining the study

Date

Witness
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APPENDIX C
DEBRIEFING FORM
Adverse Reaction Information
Thank you for your participation in this research study. While every precaution will be taken to provide an
injury- and illness-free experience, you should be aware of potential adverse reactions related to nutritional
supplementation. With almost any supplementation regimen, there is the inherent risk of unpleasant side
effects. Sodium bicarbonate supplementation is usually well-tolerated—meaning individuals rarely report
adverse reactions to the supplement. However, due to the relatively large amount of the supplement that
will be consumed during the experimental testing session of this study, you should be aware of potential
side effects. Most reported adverse effects of sodium bicarbonate supplementation involve the
gastrointestinal track. These symptoms include gas, bloating, cramping, diarrhea, and nausea. Most of these
symptoms, while uncomfortable, are manageable and do not typically preclude individuals from
participating in the research. These adverse effects are likely due to the concentrated sodium load imposed
on the gut by the supplementation. In order to minimize the potential for adverse effects, a large volume of
fluid will be consumed with the supplementation. Also, in an effort to reduce the load on the
gastrointestinal track, the supplement will be divided into four doses, consumed over a period of 30
minutes.
In the event that you do experience an adverse reaction, that reaction will likely be short-lived. If you start
feeling ill in the time period after the exercise protocol, drinking cold water, lying down, and/or applying a
cold compress to your head may help alleviate symptoms. If you start feeling ill before or during the
exercise protocol, please notify the researcher or assistants immediately. Every effort will be made to help
you manage any negative side effects. Mr. Ben Carr will either be present or on call at all times should a
research-related injury or illness occur. Should you experience such a problem, please call Ben Carr at
(601) 421-2195 (cell) or (601) 968-8964 (office). In the event that you are unable to reach Mr. Carr, you
may also call Dr. Don Berryhill at (601) 974-6458 (office) or the Belhaven Athletic Training staff at (601)
968- 8789. In the event that it is determined that you need the attention of a physician, you will be referred
to either your personal physician, the physician at the Belhaven clinic, or one of the local emergency
rooms. Any of these physicians will be available to you, but there will be a fee involved in use of their
services.
Always keep in mind that your participation is completely voluntary. If you experience an adverse reaction
and choose to no longer participate in the study, then that is certainly your prerogative. Your wellbeing is a
top priority to the researcher and assistants.

I have been fully debriefed and the researcher and/or research assistant has offered to answer any and all of
my questions related to this research study.
Print Name_____________________________________
Sign Name _____________________________________
Date____________
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APPENDIX D
HEALTH HISTORY AND PHYSICAL ACTIVITY QUESTIONNAIRE
Belhaven University
Department of Sports Medicine & Exercise Science
In conjunction with the University of Southern Mississippi
Pre-Participation Health Screening and Risk Stratification Form
Information you provide will be treated as personal and confidential. This information will enable
us to better understand your health status and fitness habits. The intent of this form is not to treat
or diagnose any illnesses, but rather to evaluate your risk for an adverse exercise- or
supplementation-related event. Please direct any questions pertaining to this form to laboratory
personnel. Do not put your name on this form.
Subject ID Number
(NOT your SSN; will be provided by researcher)
Height

Date
(mm/dd/yyyy)

Age

Gender

Weight

Section I.

Known Cardiovascular, Pulmonary, and Metabolic Disease

Race

Have you ever had (or currently have) any of the following? Circle “yes” or “no” for each
disease:
a. Cardiovascular Disorders
Cardiovascular disease (CVD)

Yes

No

Angina (chest pain)

Yes

No

Peripheral artery disease (PAD)

Yes

No

Hypertension (high blood pressure)

Yes

No

Cerebrovascular disease

Yes

No

Heart clicks (abnormal heart sounds)

Yes

No

Stroke

Yes

No

Heart murmur

Yes

No

Coronary artery disease (CAD)

Yes

No

Emboli (abnormal blood particles)
Heart attack

Yes
Yes

No
No
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Heart surgery

Yes

No

Angioplasty (surgical opening of a heart artery)

Yes

No

Phlebitis (inflammation of a vein)

Yes

No

Anemia

Yes

No

Chronic obstructive pulmonary disease (COPD)

Yes

No

Asthma

Yes

No

Interstitial lung disease (tissues surrounding lung)

Yes

No

Cystic fibrosis

Yes

No

Emphysema (lung disease)

Yes

No

Bronchitis (lung inflammation)

Yes

No

Diabetes (type 1 or type 2)

Yes

No

Thyroid disorders

Yes

No

Renal (kidney) or hepatic (liver) disease

Yes

No

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
No
No

b. Pulmonary Disorders

c. Metabolic Disorders

d. Other Disorders
Cancer
Emotional disorders
Eating disorders
Osteoporosis (decreased bone mass/density)
Epilepsy
Gastrointestinal disorders
Stomach ulcers
Digestive disorders

e. Do you have ANY disorders or problems not listed above?

Yes

No

If you answered “yes” please provide details:
f.

Do you know of or suspect ANY reason (medical, health, or otherwise) why you should not
participate in this study?
Yes
No
If you answered “yes” please provide details:
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Section II.

Major Signs and Symptoms Suggestive of Cardiovascular, Pulmonary, and
Metabolic Disease

Have you ever experienced any of the following? Circle “yes” or “no” for each sign or symptom:
Yes

No

1. Pain, discomfort, tightness, or numbness in the chest, neck, jaw, or arms

Yes

No

2. Shortness of breath at rest or with mild exertion

Yes

No

3. Dizziness or fainting

Yes

No

4. Difficult, labored, or painful breathing during the day or at night

Yes

No

5. Ankle swelling

Yes

No

6. Rapid pulse or heart rate (palpitations)

Yes

No

7. Intermittent muscle cramping

Yes

No

8. Known heart murmur

Yes

No

9. Unusual fatigue or shortness of breath with usual activities

If you answered “YES” to any of the above:
How often do you experience the sign or symptom?
Have you ever discussed the sign or symptom with a doctor?

Yes

No

Please explain the sign or symptom in more detail:

Section III.

Atherosclerotic Cardiovascular Disease Risk Factors

Yes

No

1.

Are you ≥ 45 years old (if male) or ≥ 55 years old (if female)?

Yes

No

2.

Has your father or brother experienced a heart attack (or cardiovascular
surgery) before the age of 55, or has your mother or sister experienced a
heart attack (or cardiovascular surgery) before the age of 65?

Yes

No

3.

Do you currently smoke, have quit smoking within the past 6 months, or
are regularly exposed to environmental tobacco smoke (e.g. second-hand
smoke)?

Yes

No

4.

Do you have a “sedentary” lifestyle? (less than 30 minutes of
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moderate intensity physical activity less than 3 days per week)
Do you have a body mass index (BMI) ≥ 30, waist girth > 102 cm (> 39
in.) if male, or waist girth > 88 cm (> 35 in.) if female? (measured and
indicated to you by the investigator)

Yes

No

5.

Yes

No

6.

Has your medical doctor ever told you that you have high blood pressure
(hypertension) or are you on medication to control your blood pressure?

Yes

No

7.

Has your medical doctor ever told you that you have high blood
cholesterol (hypercholesterolemia) or are you on medication to control
your cholesterol?
Total cholesterol:

Yes

No

Section IV.

8.

HDL:

Date Tested:

Has your medical doctor ever told you that you have an “impaired” or
high fasting blood glucose level (measurement of blood glucose taken
after you have not eaten for 12-14 hours) or impaired glucose tolerance
following an oral glucose tolerance test (OGTT) (measurement of blood
glucose taken after consuming a sugary drink or slice of bread)?

Questions Relating Specifically to the Present Research Study
[The Effects of Sodium Bicarbonate Supplementation on Lower-Body
Hypertrophy-Type Resistance Exercise]

a. General Safety
Yes

No

1.

Do you have arthritis or any bone or joint problem?
If yes, please explain:

Yes

No

2.

Are you taking any medications?
Name them and their dosage (both prescribed and over-the-counter
medications)

Yes

No

3.

Do you currently take a multivitamin?

Yes

No

Yes

No

5.

Do you use drugs of any kind?

Yes

No

6.

Do you currently use tobacco of any kind?

Yes
Yes

No
No

7.
8.

Has your weight been unstable for the past month?
Are you on a collegiate athletic team?

4.

Do you currently take any kind of performance-enhancing supplement
(e.g. creatine, HMB, androstenedione, etc)?
If so, what are you taking? ________________________________
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Yes

No

9.

Have you had any signs and symptoms of illness or within the past seven
days?

Yes

No

10.

Have participated in a resistance training program for a minimum of the
past two years?

b. Physical Activity, Training, and Injury Status
A. Do you currently participate in resistance exercise (e.g. weightlifting)? Yes

No

B. How many times per week do you participate in resistance exercise? ________________
C. In general, what is your training goal? ________________________________________
D. On average, how long do you participate in resistance exercise per exercise session?
_______________________________________________________________________
E. What type of resistance exercises do you perform?
_______________________________________________________________________
F. Are you currently injured?
 Yes

 No

If yes what is the nature of your injury:
G. Have you suffered an injury to your lower limbs or lower back in the last 6 months?
 Yes

 No

If yes what was the nature of your injury:
H. Are you currently suffering from any symptoms of gastrointestinal distress (e.g. nausea,
cramping, diarrhea, etc.)?
 Yes

 No

If yes what symptoms are you experiencing?:
I.

Do you know of any reasons why you should not participate in this research study?
 Yes

 No

If yes please state the reason:
J. How frequently do you consume caffeinated beverages?:
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By checking the box below I certify that all of the above is true, to the best of my knowledge.
Check here 

Date:

END OF FORM
LABORATORY USE ONLY

ACSM Risk Stratification Summary
Section I
Known or diagnosed disease?

Yes

No

[if yes exclude from study]

Section II
Major signs or symptoms?

Yes

No

[if yes exclude from study]

Section III
Number of cardiovascular risk factors: 0

1

>1

[if > 1 exclude from study]

Risk Stratification (circle one): Low Risk

Moderate Risk

High Risk

Other
Resting blood pressure:

Resting Heart Rate:

Do medications affect BP or HR?

 Yes

Date:

Staff initials:

 No

Physical Activity, Exercise, and Training Criteria for the Present Research Study
[The Effects of Echinacea-Induced Erythropoietin Production on Erythropoiesis, Oxygen
Transport, and Exercise Capacity]
Does the prospective research participant meet the training criteria, “recreationally trained”, for
this investigation?
Yes
No
(Recreationally trained for this investigation will consist of performing cardiorespiratory
exercise 3-5 days·week-1, 20-60 minutes·session-1, at 40% and 50% to 85% VO2R or HRR, or 64%
and 70% to 94% of HRmax (American College of Sports Medicine [ACSM] Guidelines for
Exercise Testing and Prescription)
Comments
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MEDICAL DOCTOR REFERRAL FORM
(Only provided to “Moderate Risk” or “High Risk” Participants)

ACSM Risk Stratification Summary
Section I
Known or diagnosed disease?

Yes

No

[if yes exclude from study]

Section II
Major signs or symptoms?

Yes

No

[if yes exclude from study]

Section III
Number of cardiovascular risk factors: 0

1

Risk Stratification (assigned by researcher):

Low Risk

>1

[if > 1 exclude from study]
Moderate Risk

High Risk

The Risk Stratification process assigns participants into one of three risk categories:
“Low Risk”, “Moderate Risk”, and “High Risk”.
The “Low Risk” classification is assigned to individuals who: (a) do not have any
signs/symptoms of cardiovascular, pulmonary, and/or metabolic disease, (b) do not have a
diagnosed cardiovascular, pulmonary, and/or metabolic disease, and (c) have no more than one
(i.e., ≤ 1) cardiovascular disease risk factor. All three of these requirements must be met for a
“Low Risk” classification. For individuals classified as “Low Risk”, the risk of an acute
cardiovascular event is low. Therefore, a physical activity and/or exercise program may be
followed safely without the need for a medical examination, physician clearance, or physician
supervision (1).
The “Moderate Risk” classification is assigned to individuals who: (a) do not have
signs/symptoms of cardiovascular, pulmonary, and/or metabolic disease, (b) do not have a
diagnosed cardiovascular, pulmonary, and/or metabolic disease, but (c) have two or more (i.e., ≥
2) cardiovascular disease risk factors. For individuals classified as “Moderate Risk”, the risk of an
acute cardiovascular event is increased. Most individuals who are classified as “Moderate Risk”
may safely perform low- to moderate-intensity physical activities and/or exercise without the
need for a medical examination, physician clearance, or physician supervision. Before “Moderate
Risk” individuals participate in vigorous-intensity exercise, it is recommended to have a medical
examination, an exercise test, and physician supervision of the exercise test (1).
The “High Risk” classification is assigned to individuals who: (a) have one or more
signs/symptoms of cardiovascular, pulmonary, and/or metabolic disease, or (b) have one or more
diagnosed cardiovascular, pulmonary, and/or metabolic disease. For individuals classified as
“High Risk”, the risk of an acute cardiovascular event is increased to the degree that requires a
thorough medical examination to take place and physician clearance is required before this
population can begin physical activity or exercise at any intensity (low-, moderate-, or vigorousintensity) (1).
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1. American College of Sports Medicine (ACSM). American College of Sports Medicine’s
Guidelines for Exercise Testing and Prescription. 8th edition. Lippincott Williams &
Wilkins, Baltimore, MD; 2010.
Signatures:
I, the undersigned, have understood the explanation by the researcher of the risk
stratification process that assigns individuals into one of three risk categories: (a) “Low Risk”, (b)
“Moderate Risk”, or (3) “High Risk”. The signing of this form indicates that I have understood
the medical referral by the researcher based on the assigned risk category of “Moderate Risk” to
consult my physician or other appropriate health care provider before engaging in vigorousintensity exercise and/or exercise testing; or the assigned risk category of “High Risk” to consult
my physician before engaging physical activity or exercise of any intensity. I understand that the
risk stratification process is simply a screening process, and is not intended as an attempt by the
researchers to diagnose or treat any disease or medical conditions.
__________________________________
Signature of Participant
Date

__________________________________
Signature of Researcher
Date

__________________________________
Name of Participant (print)

__________________________________
Name of Researcher (print)
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APPENDIX E
DATA COLLECTION SHEETS
Visit 1
Data Sheet
Subject Number: ________

Exercise

Attempt #

Date: _____________

Weight (lbs)

Repetitions to Failure

1

_________

_________

Settings

2

_________

_________

Rack:

3

_________

_________

Rails:

4

_________

_________

5

_________

_________

Squat

_______________________________________________________
Leg Press

1

_________

_________

2

_________

_________

3

_________

_________

4

_________

_________

5

_________

_________

_______________________________________________________
Knee Ext

1

_________

_________

Settings

2

_________

_________

Back:

3

_________

_________

Ankle:

4

_________

_________

5

_________

_________
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Visit 2a
Data Sheet

Subject Number: ________

Date: _____________

Exercise

Est 1RM (lbs) %1RM Weight (lbs)

Squat

______

90 sec b/t sets

Plates/side

______

90 sec b/t sets

_____

1

_____

70

_____

2

_____

70

_____

3

_____

65

_____

4

_____

Total Reps:

______

60 sec b/t sets

_____

1

_____

65

_____

2

_____

60

_____

3

_____

60

_____

4

_____

Total Reps:
70

_____

70

______

Machine

_____

1

_____

_____

2

_____

65

_____

3

_____

65

_____

4

_____

*3-minute rest*
Knee Ext PT

_____

65

*2-minute rest*
Knee Ext

RM

75

*2-minute rest*
Leg Press

Set #

Total Reps:
50

_____

_____
_____

Total Volume (pre PT): _____ reps
Overall Total Volume: _____ reps
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Visit 2b(c, if needed)
Data Sheet
Subject Number: ________

Date: _____________

Exercise

Est 1RM (lbs) %1RM Weight (lbs)

Squat

______

90 sec b/t sets

Plates/side

______

90 sec b/t sets

_____

1

_____

____

_____

2

_____

____

_____

3

_____

____

_____

4

_____

Total Reps:

______

60 sec b/t sets

_____

1

_____

____

_____

2

_____

____

_____

3

_____

____

_____

4

_____

Total Reps:
____

_____

____

______

Machine

_____

1

_____

_____

2

_____

____

_____

3

_____

____

_____

4

_____

*3-minute rest*
Leg Ext PT

_____

____

*2-minute rest*
Knee Ext

RM

____

*2-minute rest*
Leg Press

Set #

Total Reps:
50

_____

_____
_____

Total Volume (pre PT): _____ reps
Overall Total Volume: _____ reps
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Visit 3 (or 4)
Data Sheet
Supplementation: _______

Subject Number: ________

Exercise

Est 1RM (lbs) %1RM Weight (lbs)

Squat

______

90 sec b/t sets

Plates/side

______

90 sec b/t sets

______

60 sec b/t sets

1

_____

____

_____

2

_____

____

_____

3

_____

____

_____

4

_____

Total Reps:

______

_____

____

_____

1

_____

____

_____

2

_____

____

_____

3

_____

____

_____

4

_____

Total Reps:
____

_____

____

Machine

_____

1

_____

_____

2

_____

____

_____

3

_____

____

_____

4

_____

*3-minute rest*
Knee Ext PT

RM

_____

*2-minute rest*
Knee Ext

Set #

____

*2-minute rest*
Leg Press

Date: _____________

Total Reps:
50

_____

_____
_____

Total Volume (pre PT): _____ reps
Overall Total Volume: _____ reps
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Visit 3 (or 4) Continued
Data Sheet
Blood Sample—2
Blood Sample—Ref Values

Temp: _____ ºC

Temp: 37 ºC

pH:

pH:

PCO2: _____ mm Hg

7.35-7.45

_____

PCO2: 35-45 mm Hg

PO2:

PO2:

O2 sat: _____ %

75-100 mm Hg

_____ mm Hg

HCO3: 22-26 mEq/l

HCO3: _____ mEq/l

O2 sat: 92-100 %

TCO2: _____ mEq/l

BE:

BE:

_____ mEq/l

Lac:

_____ mM

0 ± 3 mEq/l

Blood Sample—3
Temp: _____ ºC
Blood Sample—Baseline

pH:

Temp: _____ ºC

PCO2: _____ mm Hg

pH:

PO2:

_____

_____
_____ mm Hg

PCO2: _____ mm Hg

O2 sat: _____ %

PO2:

HCO3: _____ mEq/l

_____ mm Hg

O2 sat: _____ %

TCO2: _____ mEq/l

HCO3: _____ mEq/l

BE:

_____ mEq/l

TCO2: _____ mEq/l

Lac:

_____ mM

BE:

_____ mEq/l

Blood Sample—4

Lac:

_____ mM

Temp: _____ ºC
pH:

_____

PCO2: _____ mm Hg
PO2:

_____ mm Hg

O2 sat: _____ %
HCO3: _____ mEq/l
TCO2: _____ mEq/l
BE:

_____ mEq/l

Lac:

_____ mM
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APPENDIX F
SUBJECT RAW DATA
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APPENDIX G
STATISTICAL ANALYSES
Dependent Samples t-tests for Performance Data
Paired Differences
Mean
Pair 1

NaHCO3 Squat (SQ) Reps

SD

SEM

t

df

Sig. (2-tailed)

1.66667 4.05268

1.16991

1.425

11

.182

2.91667 4.88892

1.41131

2.067

11

.063

4.58333 5.72805

1.65355

2.772

11

.018

.83333

1.000

11

.339

3.75000 6.42615

1.85507

2.021

11

.068

5.41667 6.89477

1.99035

2.721

11

.020

.91667

1.727

11

.112

2.35166

2.977

11

.013

Plac SQ Reps
Pair 2

NaHCO3 Leg Press (LP)
Reps Plac LP Reps

Pair 3

NaHCO3 SQ + LP
Plac SQ + LP

Pair 4

NaHCO3 Knee Ext (KE) Reps .83333

2.88675

Plac KE Reps
Pair 5

NaHCO3 LP + KE
Plac LP + KE

Pair 6

NaHCO3 SQ + LP + KE
Plac SQ + LP + KE

Pair 7

NaHCO3 Perf Test (PT) Reps 1.58333 3.17543
Plac PT Reps

Pair 8

NaHCO3 SQ + LP + KE + PT 7.00000 8.14639
Plac SQ + LP + KE + PT
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Repeated Meaures ANOVA and Post Hoc Testing for Blood Acid-Base Data
Parameter: pH
Sphericity Assumed
Time
Greenhouse-Geisser

Type III SS df
.335
3
.335
1.382

Mean Square
.112
.242

F
168.114
168.114

Sig.
.000
.000

Trial

Between Treatments .053

1

.053

27.490

.000

Time * Trial

Sphericity Assumed .015
Greenhouse-Geisser .015

3
1.382

.005
.011

7.570
7.570

.000
.005

Paired Samples Post Hoc Test
Parameter: pH

df

t

Sig.

Parameter: pH

df

t

Sig.

Pair 1

pH_BS1_NaHCO3
11
pH_BS2_NaHCO3

-8.710

.000

Pair 9

pH_BS1_plac
pH_BS4_plac

11

10.654 .000

Pair 2

pH_BS1_NaHCO3
11
pH_BS3_NaHCO3

6.799

.000

Pair 10

pH_BS2_plac
pH_BS3_plac

11

9.319

.000

Pair 3

pH_BS1_NaHCO3
11
pH_BS4_NaHCO3

5.734

.000

Pair 11

pH_BS2_plac
pH_BS4_plac

11

9.059

.000

Pair 4

pH_BS2_NaHCO3
11
pH_BS3_NaHCO3

12.670 .000

Pair 12

pH_BS3_plac
pH_BS4_plac

11

-3.625

.004

Pair 5

pH_BS2_NaHCO3
11
pH_BS4_NaHCO3

10.763 .000

Pair 13

pH_BS1_ NaHCO3
11
pH_BS1_plac

1.091

.299

Pair 6

pH_BS3_NaHCO3
11
pH_BS4_NaHCO3

-1.688

.119

Pair 14

pH_BS2_ NaHCO3
11
pH_BS2_plac

9.177

.000

Pair 7

pH_BS1_plac pH_BS2_plac

11

1.420

.183

Pair 15

pH_BS3_ NaHCO3
11
pH_BS3_plac

8.803

.000

Pair 8

pH_BS1_plac pH_BS3_plac

11

10.747 .000

Pair 16

pH_BS4_ NaHCO3
11
pH_BS4_plac

7.716

.000
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Parameter: HCO3Sphericity Assumed
Time
Greenhouse-Geisser

Type III SS df
3200.247
3
3200.247
1.269

Mean Square
1066.749
2520.973

F
297.573
297.573

Sig.
.000
.000

Trial

Between Treatments 241.300

1

241.300

12.090

.002

Time * Trial

Sphericity Assumed 94.859
Greenhouse-Geisser 94.859

3
1.269

31.620
74.724

8.820
8.820

.000
.004

df t

Sig.

Paired Samples Post Hoc Test
Parameter: HCO3-

df t

Parameter: HCO3-

Sig.

Pair 1

HCO3_BS1_NaHCO3
11 -10.966 .000
HCO3_BS2_NaHCO3

Pair 9

HCO3_BS1_plac
HCO3_BS4_plac

11 12.141 .000

Pair 2

HCO3_BS1_NaHCO3
11 9.678
HCO3_BS3_NaHCO3

.000

Pair 10

HCO3_BS2_plac
HCO3_BS3_plac

11 13.552 .000

Pair 3

HCO3_BS1_NaHCO3
11 8.626
HCO3_BS4_NaHCO3

.000

Pair 11

HCO3_BS2_plac
HCO3_BS4_plac

11 13.040 .000

Pair 4

HCO3_BS2_NaHCO3
11 15.210 .000
HCO3_BS3_NaHCO3

Pair 12

HCO3_BS3_plac
HCO3_BS4_plac

11 -4.346

Pair 5

HCO3_BS2_NaHCO3
11 14.333 .000
HCO3_BS4_NaHCO3

Pair 13

HCO3_BS1_ NaHCO3
11 .984
HCO3_BS1_plac

Pair 6

HCO3_BS3_NaHCO3

HCO3_BS4_NaHCO3

.001
.346

11 -7.557

.000

Pair 14

HCO3_BS2_ NaHCO3
11 11.805 .000
HCO3_BS2_plac

Pair 7

HCO3_BS1_plac HCO3_BS2_plac

11 .939

.368

Pair 15

HCO3_BS3_ NaHCO3
11 6.449
HCO3_BS3_plac

.000

Pair 8

HCO3_BS1_plac HCO3_BS3_plac

11 13.205 .000

Pair 16

HCO3_BS4_ NaHCO3
11 6.655
HCO3_BS4_plac

.000
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Parameter: BE
Sphericity Assumed
Time
Greenhouse-Geisser

Type III SS df
4330.208
3
4330.208
1.256

Mean Square
1443.403
3446.680

F
271.377
271.377

Sig.
.000
.000

Trial

Between Treatments 352.667

1

352.667

15.214

.001

Time * Trial

Sphericity Assumed 117.750
Greenhouse-Geisser 117.750

3
1.256

39.250
93.724

7.379
7.379

.000
.008

Paired Samples Post Hoc Test
Parameter: BE

df

t

Parameter: BE

Sig.

df

t

Sig.

Pair 1

BE_BS1_NaHCO3
11
BE_BS2_NaHCO3

-10.392 .000

Pair 9

BE_BS1_plac
BE_BS4_plac

11

11.455 .000

Pair 2

BE_BS1_NaHCO3
11
BE_BS3_NaHCO3

8.922

.000

Pair 10

BE_BS2_plac
BE_BS3_plac

11

12.764 .000

Pair 3

BE_BS1_NaHCO3
11
BE_BS4_NaHCO3

8.186

.000

Pair 11

BE_BS2_plac
BE_BS4_plac

11

11.397 .000

Pair 4

BE_BS2_NaHCO3
11
BE_BS3_NaHCO3

15.014 .000

Pair 12

BE_BS3_plac
BE_BS4_plac

11

-4.690

.001

Pair 5

BE_BS2_NaHCO3
11
BE_BS4_NaHCO3

14.672 .000

Pair 13

BE_BS1_ NaHCO3
11
BE_BS1_plac

1.000

.339

Pair 6

BE_BS3_NaHCO3
11
BE_BS4_NaHCO3

-4.168

.002

Pair 14

BE_BS2_ NaHCO3
11
BE_BS2_plac

10.922 .000

Pair 7

BE_BS1_plac BE_BS2_plac

11

.713

.491

Pair 15

BE_BS3_ NaHCO3
11
BE_BS3_plac

7.000

.000

Pair 8

BE_BS1_plac BE_BS3_plac

11

12.881 .000

Pair 16

BE_BS4_ NaHCO3
11
BE_BS4_plac

6.993

.000
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Parameter: LacSphericity Assumed
Time
Greenhouse-Geisser

Type III SS df

Mean Square

F

Sig.

5391.352
5391.352

3
1.109

1797.117
4862.610

1080.283
1080.283

.000
.000

Trial

Between Treatments 352.667

1

352.667

15.214

.001

Time * Trial

Sphericity Assumed 32.261
Greenhouse-Geisser 32.261

3
1.109

10.754
29.097

6.464
6.464

.001
.015

df t

Sig.

Paired Samples Post Hoc Test
Parameter: Lac-

df t

Sig.
.000

Pair 1

Lac_BS1_NaHCO3
Lac _BS2_NaHCO3

11 -5.327

Pair 2

Lac _BS1_NaHCO3
Lac _BS3_NaHCO3

Pair 3

Parameter: LacPair 9

Lac _BS1_plac
Lac _BS4_plac

11 -19.585 .000

11 -29.425 .000

Pair 10

Lac _BS2_plac
Lac _BS3_plac

11 -21.024 .000

Lac_BS1_NaHCO3
Lac _BS4_NaHCO3

11 -27.650 .000

Pair 11

Lac _BS2_plac
Lac _BS4_plac

11 -20.526 .000

Pair 4

Lac _BS2_NaHCO3
Lac _BS3_NaHCO3

11 -26.808 .000

Pair 12

Lac _BS3_plac
Lac _BS4_plac

11 5.073

Pair 5

Lac _BS2_NaHCO3
Lac _BS4_NaHCO3

11 -25.798 .000

Pair 13

Lac _BS1_ NaHCO3
11 -1.436
Lac _BS1_plac

.179

Pair 6

Lac _BS3_NaHCO3
11 4.965
Lac _BS4_NaHCO3

.000

Pair 14

Lac _BS2_ NaHCO3
11 1.171
Lac _BS2_plac

.266

Pair 7

Lac _BS1_plac
Lac _BS2_plac

11 -3.465

.005

Pair 15

Lac _BS3_ NaHCO3
11 8.347
Lac _BS3_plac

.000

Pair 8

Lac _BS1_plac
Lac _BS3_plac

11 -20.162 .000

Pair 16

Lac _BS4_ NaHCO3
11 7.908
Lac _BS4_plac

.000

.000
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